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ognitive behaviour therapy (CBT) is an evidence-based intervention for patients who 
suffer from chronic fatigue syndrome (CFS). The six empirical studies which are 
presented in this thesis seek to answer the questions why CBT for CFS works and how it can 
be successfully implemented outside specialised treatment settings. This first chapter gives a 
general introduction to the topic and an outline of the thesis. 
 
CHRONIC FATIGUE SYNDROME 
CFS is characterised by severe fatigue which lasts for at least six months. Additional 
complaints such as pain, concentration problems and unrefreshing sleep are frequently 
reported. These complaints are not the result of a medical condition and lead to substantial 
impairment in areas such as physical, social and work related activities (Fukuda et al., 1994). 
Spontaneous recovery in CFS is uncommon, especially in patients with an illness duration of 
more than two years (van der Werf et al., 2002; Cairns & Hotopf, 2005). In the Netherlands, 
an estimated number of 30.000 to 40.000 people are suffering from CFS (Gezondheidsraad, 
2005). 
The aetiology of CFS is largely unknown but the differentiation between predisposing, 
precipitating and perpetuating factors has been fruitful in the past two decades, especially for 
the design of evidence-based interventions (Prins et al., 2006). Predisposing factors are 
factors that make people vulnerable to develop CFS, such as perfectionism or childhood 
maltreatment. Precipitating factors are factors that trigger somatic complaints, such as a viral 
infection or psychological stress. In most individuals, these complaints will stop as soon as 
the trigger has disappeared. In some people, especially those who are vulnerable to develop 
CFS, perpetuating factors can cause the persistence of the somatic complaints long after the 
initial trigger has disappeared.  
Our research group has developed and tested a model of perpetuating factors which is 
depicted in figure 1. According to this model, the symptomatology of CFS patients is 
perpetuated by a low level of physical activity, which is caused by the tendency to attribute 
the symptoms to a somatic cause, a low level of perceived control over fatigue and a focus on 
symptoms (Vercoulen et al., 1998). Subsequent research has shown that a lack of social 
support and the reactions of others are relevant for the perpetuation of CFS as well (Prins et 
al., 2004). 
C 
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Figure 1: Adaptation of the model of perpetuating factors introduced by Vercoulen et al. (1998). 
  
  
 
 
 
 
 
 
 
 
COGNITIVE BEHAVIOUR THERAPY FOR CFS 
Cognitive behavioural interventions are designed to intervene in the perpetuating factors of 
CFS (Sharpe et al., 1996; Deale et al., 1998; Prins et al., 2001). The treatment approach of our 
group is based on the insights of the model of perpetuating factors introduced by Vercoulen et 
al. (1998). In this variant of CBT for CFS, somatic attributions are discussed with the patient 
based on the medical examination report in which a somatic cause for the symptoms has been 
excluded (Bleijenberg et al., 2003; Knoop et al., 2010). The model of perpetuating factors is 
then discussed to enhance the patient’s understanding of the role that cognitive and 
behavioural processes can play in the persistence of the symptoms. The treatment is divided 
into three parts. 
 In the preparation period, personalised goals are formulated. The overall goal of 
treatment is recovery in terms of impairment and fatigue severity (Knoop, 2007a). A regular 
pattern of bedtimes is then established to stop the disruption of the circadian rhythm. Next, 
cognitive techniques are introduced to teach patients how to recognise and challenge non-
accepting and catastrophising thoughts which inhibit adequate coping. Patients are also taught 
how to decrease their focus on symptoms by distracting their attention from their fatigue. In 
addition, relatively active patients learn how to spread their activities more evenly across the 
day to avoid deregulation. Relatively active patients are characterised by bursts of activity 
followed by periods of prolonged rest (van der Werf et al., 2000). In contrast to these patients, 
pervasively passive patients have extremely low activity levels on virtually all days. These 
patients start with part two of the treatment directly after the cognitive interventions. 
Sense of 
control 
Focusing on 
symptoms 
Somatic 
attribution 
 
IMPAIRMENT 
Physical 
activity 
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Social support and 
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In the second part of treatment, the low level of physical activity is targeted by a gradual 
increase in walking or bicycling. Dysfunctional illness beliefs, such as the idea that even 
moderate levels of activity can do harm, are systematically challenged in this period. When 
patients have increased their level of physical activity appropriately (usually about 45 minutes 
twice a day), they are stimulated to realise their personal goals in part three of the treatment. 
These goals usually include the resumption of work, hobbies and other activities that imply 
recovery for the patient. While the increase in walking or bicycling was largely determined by 
the therapist, patients are now taking direct control of the gradual realisation of their personal 
goals to further increase the sense of control over symptoms. When the personal goals are 
realised, patients are stimulated to experiment with fluctuating bedtimes and levels of activity 
to further normalise the feeling of fatigue as part of an active and healthy life. 
 This cognitive behavioural strategy has been tested in adult and adolescent patients (Prins 
et al., 2001; Stulemeijer, 2005) and more recently also as low intensity variant in which self-
guided instructions are accompanied by e-mail contact with a trained therapist (Knoop, 2008). 
All of these studies showed a significant effect of treatment on fatigue and impairment. 
Additional symptoms, such as pain and concentration problems, were also reduced (Knoop et 
al, 2007b; 2007c). These findings are in line with other randomised controlled trials (RCTs) 
about the efficacy of CBT for CFS (Sharpe et al., 1996; Deale et al., 1997; White et al., 2011). 
Several systematic reviews confirmed that CBT is an evidence-based intervention for the 
treatment of CFS patients (e.g. Price et al., 2008; Malouff et al., 2008; Bronwyn et al., 2011). 
 
VALIDATION OF THE CBT FOR CFS MODEL 
The basic idea of CBT for CFS is that a favourable change in the perpetuating factors will 
result in a reduction of symptomatology. Although past research has been testing extensively 
whether CBT yields a significant effect in CFS patients, it has remained unclear whether the 
perpetuating factors are actually changed by treatment and whether it is this change that can 
explain the decrease in symptomatology. An empirical test of these hypotheses can contribute 
substantially to the validation of current treatment models. A better knowledge about the 
mechanisms of change that are at work in CBT for CFS can also stimulate the development of 
more effective and efficient interventions for CFS patients in the future.  Following the model 
of perpetuating factors (Vercoulen et al., 1998), three different mechanisms may characterise 
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effective interventions for CFS. First, the level of activity should be increased. Different 
opinions are held about why a change in activity may be beneficial. Some have argued that an 
increased level of physical activity reverses physical deconditioning (Fulcher et al., 1997; 
Wearden et al., 1998). Others have argued that a systematic increase in activity undermines 
avoidance behaviours which inhibit adaptive coping in CFS patients (Surawy et al., 1995; 
Deale et al., 1998). Such behaviours might be maintained through dysfunctional illness 
beliefs. A core belief of CFS patients is the assumption of having an uncontrollable disease. 
This belief is represented in the model of perpetuating factors by the factor sense of control 
over symptoms which should be increased as well.  
 Third, the focus on symptoms should be decreased. The underlying idea of this 
intervention is that dysfunctional cognitive processes can be disrupted by distracting attention. 
Task concentration training in social phobia, where patients learn how to pay attention to their 
surrounding instead of focusing on bodily symptoms such as blushing or sweating (Bögels et 
al., 2006), is based on the same idea. Moss-Morris et al. (2005) examined the mechanisms of 
change in graded exercise therapy (GET) for CFS. In GET, the level of physical fitness is 
increased on exercise equipment which has been shown to reduce symptomatology in CFS 
patients as well (Edmonds et al., 2004; Chambers et al., 2006). Although this intervention was 
designed to increase the level of fitness to reduce symptomatology, a decrease in focusing on 
symptoms mediated the effect of treatment in the study of Moss-Morris et al. (2005). 
 
IMPLEMENTATION OF EVIDENCE-BASED PRACTICE FOR CFS 
It has been mentioned before that CBT is an evidence-based intervention for CFS patients and 
that the course of symptomatology in these patients is generally sober without treatment 
(Cairns et al., 2005; Price et al., 2008; Malouff et al., 2008). The Dutch health council 
therefore concluded that CBT for CFS should also be delivered outside specialised therapy 
settings to increase treatment capacities and to reduce societal costs for medical consultation 
and sick leave (Gezondheidsraad, 2005). Our group has suggested national implementation of 
CBT for CFS in community-based mental health care centres (MHCs). In MHCs, sufficient 
cognitive behavioural therapists are available and somatic attributions are not further 
encouraged (Bleijenberg et al., 2000). Scheeres et al. (2006; 2008) examined the specific 
requirements for the implementation of CBT for CFS in MHCs and assembled an 
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implementation manual for future dissemination based on their findings. The basic idea was 
that a standardised implementation manual might enable MHCs to implement and sustain 
CBT for CFS independent of external implementation support which might be a considerable 
advantage for dissemination on a national level. The implementation manual describes the 
importance of training and supervision for therapists, of activities to inform potential referrers 
and patients about the new therapy, and of handling limited waiting periods. 
 The attempt to use limited treatment capacities optimally, has also stimulated efforts to 
develop a stepped care approach for CFS. A comparison of regular CBT and stepped care for 
CFS, in which a minimal intervention was combined with regular CBT, showed that stepped 
care is equally effective but more efficient than regular CBT alone (Knoop et al., 2008; 
Tummers et al., 2010). The minimal intervention consisted of guided self-instructions which 
were based on the same principles as regular CBT for CFS including contact with a trained 
therapist per e-mail (Bleijenberg et al., 2003; Knoop et al., 2008; Knoop et al., 2010). 
 
POTENTIAL LIMITS OF EVIDENCE-BASED PRACTICE FOR CFS 
Some patients experience such severe symptoms that they feel no longer able to leave their 
home. A member survey of a British patient organisation suggested that a considerable 
number of patients is actually bound to home due to their fatigue (Action M.E., 2001). While 
the validity of this survey may be the subject of methodological discussion, it is in fact 
striking that most research in the field of CFS has been conducted with patients who are able 
to follow outpatient treatment in some way. There is hardly any knowledge about the 
characteristics of patients who feel unable to engage in care as usual because of the severity of 
their symptoms. This lack of knowledge might implicate that our research findings do not 
generalise to all CFS patients. In addition, we might systematically marginalise a group of 
patients that is in strong need for effective interventions. More insight into the characteristics 
of homebound CFS patients and their demand for professional help is thus needed to close a 
potential scientific and clinical gap in the field of CFS. 
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OUTLINE OF THE THESIS 
The Expert Centre for Chronic Fatigue of the Radboud University Nijmegen Medical Centre 
has been studying CFS and chronic fatigue in cancer survivors and chronic diseases for more 
than twenty years. Among other things, this research line has included the development and 
empirical study of CBT for CFS. Every year, several hundreds of patients who suffer from 
chronic fatigue consult the Expert Centre for assessment and treatment of their complaints. 
The purpose of this dissertation was to enhance the understanding of the mechanisms of 
successful change and implementation of CBT for CFS to further improve the quality of care 
for these patients. 
 
Physical inactivity and the effect of CBT for CFS 
A popular hypothesis about the mechanisms of change in effective treatment for CFS is the 
idea that patients need to get physically more active in order to feel less fatigued. The purpose 
of the study that is presented in chapter 2 was to determine whether the effect of CBT on 
fatigue is actually mediated by a persistent increase in physical activity. Three RCTs about 
the efficacy of cognitive behavioural interventions for CFS (Prins et al., 2001; Stulemeijer, 
2005; Knoop, 2008) were reanalysed according to the guidelines for mediation analysis of 
Baron and Kenny (1986). The hypothesised mediator physical activity was measured with 
Actometers in all studies which are small motion sensing devices that are worn around the 
ankle (van der Werf et al., 2000). 
 
Maladaptive coping and the effect of CBT for CFS 
It has also been suggested that CBT for CFS works because it changes maladaptive coping 
strategies. Most central to this hypothesis are avoidance behaviours and the focus on fatigue 
(Deale et al., 1998; Moss-Morris et al., 2005). The purpose of the study that is presented in 
chapter 3 was to determine whether the effect of CBT for CFS on fatigue and impairment is 
mediated by a persistent decrease in avoidance of activity and aversive stimuli and a 
persistent decrease in the focus on fatigue. For this purpose, we reanalysed the largest of the 
previously mentioned RCTs (Prins et al., 2001) in which the maladaptive coping strategies 
were assessed with a coping questionnaire that is frequently used in the field of chronic pain. 
We examined the factor structure of the adapted coping questionnaire in our sample of CFS 
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patients and tested our mediation hypotheses according to the guidelines of Baron et al. 
(1986).      
 
Towards an evidence-based treatment model 
In chapter 4, we present the development of a treatment model for cognitive behavioural 
interventions focusing on CFS based on the model of perpetuating factors introduced by 
Vercoulen et al. (1998). We reanalysed the most recent of our RCTs for this purpose in which 
a minimal cognitive behavioural intervention was compared to a waiting list control group 
(Knoop et al., 2008). Structural equation modelling was used to test the treatment model in 
which cognitive processes were hypothesised to play a central role. 
 
The implementation of CBT for CFS outside specialised settings 
The purpose of the study that is presented in chapter 5 was to determine whether CBT for 
CFS can be implemented and sustained by MHCs with the implementation manual introduced 
by Scheeres et al. (2006). For this purpose, we monitored the process data of three Dutch 
MHCs, one in which CBT for CFS was sustained from an earlier implementation study, one 
in which CBT was implemented as only intervention for CFS, and one in which CBT was 
implemented in the context of a stepped care program for CFS. The results of our MHCs were 
compared with the results from a previous benchmark study conducted by Scheeres et al. 
(2008).     
 
Therapist effects and the dissemination of CBT for CFS 
In chapter 6, we examined treatment outcome outside specialised settings. In particular, we 
focused on the role of therapists and their attitudes towards working with evidence-based 
treatment manuals. A scientific survey in the US has shown that the attitude of therapists 
towards standardised treatment manuals can vary considerably which may pose a problem to 
effective use of standardised treatment approaches (Addis et al., 2000). We used the routinely 
collected outcome data of our implementation study to test whether therapists would produce 
different outcomes and whether these differences might be explained by their attitude towards 
evidence-based treatment manuals. 
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Homebound CFS patients 
The last study of this dissertation is presented in chapter 7. The purpose of that study was to 
determine whether homebound patients differ from other CFS patients on illness specific 
characteristics. For this purpose, we compared a group of homebound patients with the 
natural course condition of one of our outpatient RCTs (Prins et al., 2001). Illness specific 
characteristics included assessment of fatigue, impairment and additional complaints such as 
concentration problems, unrefreshing sleep and deterioration in psychological wellbeing. 
Physical inactivity, somatic attribution and lack of control over symptoms were also included. 
We hypothesised that the scores on these characteristics would be more problematic in 
homebound patients than in outpatients.  
 
In chapter 8, the findings of the previous six chapters are discussed in more depth. 
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ABSTRACT 
Cognitive behaviour therapy (CBT) is known to reduce fatigue severity in chronic fatigue 
syndrome (CFS). How this change in symptomatology is accomplished is not yet understood. 
The purpose of the present study was to determine whether the effect of CBT on fatigue is 
mediated by an increase in physical activity. Three randomised controlled trials were 
reanalysed, previously conducted to evaluate the efficacy of CBT for CFS. In all samples, 
actigraphy was used to assess the level of physical activity prior and subsequent to treatment 
or a control group period. The mediation hypothesis was analysed according to guidelines of 
Baron and Kenny. A non-parametric bootstrap approach was used to test statistical 
significance of the mediation effect. Although CBT effectively reduced fatigue, it did not 
change the level of physical activity. Furthermore, changes in physical activity were not 
related to changes in fatigue. Across the samples, the mean mediation effect of physical 
activity averaged about 1% of the total treatment effect. This effect did not yield significance 
in any of the samples. The effect of CBT on fatigue in CFS is not mediated by a persistent 
increase in physical activity. 
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INTRODUCTION 
Chronic fatigue syndrome (CFS) is characterised by severe and disabling fatigue which 
persists at least six months and which is not the result of a medical condition or ongoing 
exertion (Fukuda et al., 1994). Cognitive behaviour therapy (CBT) has been shown to reduce 
fatigue severity and impairment in patients with CFS (Price et al., 2008; Malouff et al., 2008). 
This effect has often been attributed to an increase in activity because activity programs have 
traditionally played a central role in CBT for CFS (Sharpe et al., 1996; Deale et al., 1997; 
Bleijenberg et al., 2003; Quarmby et al., 2007). In the present study, we tested a treatment 
model in which the effect of CBT on fatigue is mediated by an increase in physical activity. 
Several studies have demonstrated that the average level of physical activity in CFS 
patients is substantially lower than in healthy controls (e.g. van der Werf et al., 2000; Black et 
al., 2005). A low level of physical activity has also been shown to perpetuate the feeling of 
severe fatigue in patients with CFS (Vercoulen et al., 1998). In some approaches of CBT for 
CFS (e.g. Bleijenberg et al., 2003), an increase in physical activity is stimulated 
systematically by asking patients to take short walks on a daily basis which are gradually 
extended in duration up to twice an hour per day. Illness related cognitions are also targeted in 
these interventions. In particular, patients’ preoccupation with their condition and the believe 
that they have little control over their symptoms are challenged. These cognitions have been 
found to perpetuate fatigue in CFS as well (Vercoulen et al., 1998). 
There are behavioural interventions for CFS which rely exclusively on a physical activity 
program to improve fatigue. According to the rationale of graded exercise therapy (GET), the 
key problem in CFS is physical deconditioning which can be overcome by enhancing the 
level of physical fitness (Fulcher & White, 1997; Wearden et al., 1998). Patients are 
stimulated to gradually increase their level of physical activity on exercise bikes or other 
equipment. Illness related cognitions are not challenged intentionally. This strategy has been 
shown to reduce fatigue in CFS as well (Edmonds et al., 2004; Chambers et al., 2006). 
By now, a substantial body of research is available to support the efficacy of 
interventions for CFS in which the level of physical activity is targeted. However, 
considerably less attention has been paid to whether the effect of these interventions actually 
depends on a change in physical parameters. Such a finding would be vital to the validation of 
all treatment models which rely on a physical activity program in some way to improve 
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fatigue. In the only study of such nature we are aware of, Moss-Morris et al. (2005) 
demonstrated that an increase in physical fitness does not contribute to the treatment effect of 
GET on fatigue in CFS. 
The purpose of the present study was to determine whether the treatment effect of CBT 
on fatigue is mediated by an increase in physical activity. In psychotherapy research, testing 
mediation is a strategy to identify variables which intervene in the relationship between 
treatment and outcome and thereby help to better understand how treatment works (Frazier et 
al., 2004). This idea is illustrated in figure 1. In part a of figure 1, a change in fatigue is 
simply explained by the allocation of treatment (path c). This model is usually tested when the 
efficacy of an intervention is of primary interest to the investigator. In part b of figure 1, the 
effect of CBT on fatigue (path c’) is mediated by a change in physical activity (path a) which 
is responsible for the change in fatigue (path b). We tested this mediation hypothesis to gain 
more insight into how CBT reduces fatigue in CFS. 
 
Figure 1: The effect of CBT on fatigue without and with the hypothesised mediator changes in physical activity. 
 
part a)             part b) 
 
 
 
                             c                 a             b 
                        
                                                     
                                                                                       
              c’ 
 
METHODS 
For the purpose of the present study we reanalysed three randomised controlled trials (RCTs), 
previously conducted to test the efficacy of CBT on CFS (Prins et al., 2001; Stulemeijer et al., 
2005; Knoop et al., 2008). Treatment was based on the manual of CBT for CFS described in 
detail by Bleijenberg et al. (2003) and effectively reduced fatigue severity in all trials. 
Patients were randomly assigned to either a treatment or a control group condition. 
Assessment took place prior and subsequent to treatment or the control group period. 
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Δ fatigue 
 
 
Δ physical activity 
 
 
 
CBT 
 
Δ fatigue 
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Samples  
The first of the three RCTs evaluated the effect of CBT on CFS (Prins et al., 2001). All 
patients were between 18 and 60 years of age and met the CDC research criteria for CFS 
(Fukuda et al., 1994), except for the four additional symptoms criterion. In total, 270 patients 
were assigned to either CBT, a guided support group, or a natural course condition. CBT 
consisted of 16 sessions of 1hour over 8 months while the guided support group had 11 
meetings of 1.5 hours over 8 months. All groups were assessed at baseline and 8 months later 
(second assessment). The results of the guided support group and the natural course condition 
were comparable in the original study (Prins et al., 2001). We therefore approached the two 
control groups as one in our analyses. 
The second RCT tested the effect of guided self-instructions on CFS (Knoop et al., 
2008). This minimal intervention consisted of written self-instructions combined with e-mail 
contact with a trained therapist. All patients were 18 years or older and met the 1994 CDC 
research criteria for CFS (Fukuda et al., 1994). In total, 169 patients were assigned to either 
the guided self-instructions or a waiting list control condition. The time between baseline and 
second assessment varied between 6 and 12 months with a mean time of 10.5 months (SD = 
4.0) in the treatment group and 9.7 months (SD = 3.6) in the control group. 
The third RCT evaluated the effect of CBT in adolescents with CFS (Stulemeijer et al., 
2005). In total, 69 patients were assigned to either CBT or a waiting list condition. All 
patients were between 10 and 17 years of age and met the 1994 CDC research criteria for CFS 
(Fukuda et al., 1994). Both groups were assessed at baseline and 5 months later (second 
assessment). CBT consisted of 10 sessions of 1 hour over 5 months. Parents of the adolescent 
patients were actively involved in the treatment process. 
 
Instruments 
Fatigue: The subscale fatigue severity of the Checklist Individual Strength (CIS) was used to 
indicate the severity of fatigue experienced by patients. It consists of eight items which are 
scored on a 7-point Likert scale. The sum score varies between 8, no fatigue, and 56, severe 
fatigue. The CIS is a reliable and valid instrument for the assessment of fatigue in CFS 
(Vercoulen et al., 1994; Dittner et al., 2004). A common cut-off score for severe fatigue is 35 
(or higher) which is about two standard deviations above the norm score for healthy patients. 
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Physical Activity: Actigraphy was used to assess physical activity in all trials. The Actometer 
is a motion sensing device which is worn around the ankle for twelve consecutive days. An 
average daily level of physical activity is computed over this period with higher scores 
indicating more physical activity. The Actometer is described in more detail by van der Werf 
et al. (2000). They found a significant difference between the mean Actometer score of CFS 
patients which was 66 (SD = 22) and healthy controls who had a mean Actometer score of 91 
(SD = 25). They also identified a group of patients who scored below the mean score of CFS 
patients on eleven out of twelve days and labelled this group as pervasively passive. We 
excluded all patients from our study who missed actigraphy at second assessment. 
 
Analyses 
We conducted one-way ANOVA’s to test whether those patients who were excluded from our 
study due to missing actigraphy at second assessment differed on baseline characteristics from 
those patients who were included. Fisher’s exact test was used in case of dichotomous 
dependent variables.  
A macro expansion for SPSS introduced by Preacher and Hayes (2004) was employed to 
conduct mediation analysis. The macro followed the standard for mediation analysis 
introduced by Baron & Kenny (1986). Paths a, b, c and c’ of figure 1 were analysed using 
regression analysis. To examine path a, changes in physical activity were regressed on 
treatment. Path b was examined by regressing changes in fatigue on changes in physical 
activity, correcting for treatment. In case of path c, changes in fatigue were regressed on 
treatment, while path c’ was examined by regressing changes in fatigue on treatment, this 
time correcting for the mediator changes in physical activity. The size of the mediation effect 
was computed by multiplying path a with path b. 
Statistical significance of the mediation effect was tested using a non-parametric 
bootstrap approach (Preacher et al., 2004). The observed dataset was randomly resampled 
5000 times with replacement which resulted in 5000 samples with mediation effect. The mean 
of these mediation effects was used as population parameter. When the 95% confidence 
interval around this parameter did not include zero, the null hypothesis was rejected. When 
the 95% confidence interval did include zero, the mediation hypothesis was rejected. This 
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procedure increased the power to detect significant effects in small, non-normally distributed 
samples. 
We analysed each trial separately because patient population (adult vs. adolescent) as 
well as presentation of treatment (face to face contact vs. guided self-instructions) differed 
considerably between the trials. Since we examined three individual trials in one study, we 
preferred a p-value of  < .017 as threshold for significance (.050 divided by 3). All change 
scores were computed by subtracting second from baseline assessment. A negative change 
score indicated decrease while a positive one indicated increase on the respective variable. 
 
RESULTS 
In table 1, the baseline characteristics of the patients who were included in our study are 
compared with those patients who were excluded due to missing actigraphy at second 
assessment. As shown, none of the differences between these two groups yielded significance 
in our analyses. 
 
Table 1: Baseline characteristics of included versus excluded patients. 
 
 
 
Prins 
 
Knoop 
 
   Stulemeijer 
  
included           excluded  
 
included 
 
excluded 
 
included 
 
excluded 
 
n (CBT) 
 
age
*
 
 
211 (70) 
 
36.9 (10.2) 
 
59 (22) 
 
36.0 (9.7) 
 
132 (58) 
 
37.9 (10.4) 
 
37 (26) 
 
38.4 (10.1) 
 
58 (28) 
 
15.7 (1.3) 
 
11 (7) 
 
15.4 (0.8) 
p .543 .785 .493 
% female (n) 78 (165)  80 (47) 77 (101) 89 (33) 90 (52) 81 (9) 
p
 **
 .860 .111 .604 
illness duration
*
 5.5 (5.4) 6.0 (6.3) 9.7 (9.9) 12.0 (10.9) 1.8 (1.3) 1.7 (1.2) 
p .566 .213 .865 
fatigue severity 52.0 (4.1) 52.9 (3.4) 49.6 (5.4) 49.2 (5.4) 51.8 (4.3) 53.4 (2.7) 
p .118 .692 .251 
physical activity 65.4 (20.4) 69.0 (26.7)
1
 63.3 (22.5) 61.9 (18.5) 65.3 (21.0) 65.7 (33.2) 
p .272 .733 .953 
% passive (n) 25 (53) 14 (8) 27 (35) 24 (9) 22 (13) 44 (4)
2 
 p
**
 .077 1.00 .216 
Note. Unless otherwise indicated, all data are mean scores (SD) and differences were examined with ANOVA.  
*
In years. 
**Fischer’s exact test. 1One patient missing. 2Two patients missing. 
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In table 2, baseline, second assessment and change scores on fatigue severity and physical 
activity are presented per treatment condition for the group of included patients. 
 
Table 2: Mean baseline, second assessment and change scores (SD) on fatigue severity and physical activity in 
the group of included patients per treatment condition. 
 
 
 
Prins (n=211) 
 
Knoop (n=132) 
 
   Stulemeijer (n=58) 
 
treatment condition 
 
CBT 
(n=70) 
 
control 
(n=141) 
 
CBT 
(n=58) 
 
control 
(n=74) 
 
CBT 
(n=28) 
 
control 
(n=30) 
fatigue severity 
   baseline 
   second assessment 
   change score 
 
52.4 (4.0) 
40.3 (10.5) 
-12.1 (10.3) 
 
51.7 (4.1) 
45.8 (8.7) 
-6.0 (9.2) 
 
49.5 (5.1) 
38.9 (10.8) 
-10.6 (11.1) 
 
49.6 (5.7) 
45.7 (8.9) 
-3.9 (8.4) 
 
52.3 (4.1) 
24.8 (14.1) 
-27.5 (14.2) 
 
51.3 (4.4) 
42.9 (13.9) 
-8.4 (13.4) 
physical activity 
   baseline 
   second assessment 
   change score 
 
67.4 (21.8) 
68.8 (25.2) 
1.4 (18.5) 
 
64.5 (19.7) 
64.9 (21.7) 
0.4 (16.4) 
 
63.1 (23.5) 
67.3 (22.5) 
4.3 (20.4) 
 
63.5 (21.8) 
67.8 (21.4) 
4.3 (21.0) 
 
65.6 (22.4) 
75.8 (21.7) 
10.3 (21.7) 
 
65.0 (20.1) 
67.7 (23.8) 
2.7 (28.1) 
 
In table 3, it can be seen that fatigue was reduced significantly more in the treatment group 
than in the control group in all samples (path c). However, CBT did not produce a significant 
change in physical activity in any of the samples (path a). 
  
Table 3: Testing paths a, b, c and c’ as depicted in figure 1. 
  
path a 
 
 
path b 
 
 
path c 
 
 
path c’ 
 
Prins 
B 
SE 
t  
p  
 
 
0.99 
2.50 
0.40 
.693 
 
 
-0.04 
0.04 
-1.07 
.285 
 
 
-6.11 
1.40 
-4.36 
<.001 
 
 
-6.07 
1.40 
-4.33 
<.001 
Knoop 
B 
SE 
t  
p  
 
-0.00 
3.64 
-0.00 
.999 
 
-0.08 
0.04 
-2.00 
.047 
 
-6.64 
1.70 
-3.91 
<.001 
 
-6.64 
1.68 
-3.95 
<.001 
Stulemeijer 
B 
SE 
t  
p  
 
7.58 
6.63 
1.14 
.257 
 
-0.10 
0.07 
-1.40 
.178 
 
-19.10 
3.63 
-5.27 
<.001 
 
-18.35 
3.64 
-5.04 
<.001 
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There was also no significant relationship between changes in physical activity and changes 
in fatigue (path b). The effect of treatment on fatigue remained significant when it was 
controlled for changes in physical activity (path c’).  
In table 4, results of the bootstrap analysis are shown. Resampling of the observed data 
set resulted in a mean mediation effect with a 95% confidence interval for each sample. The 
mean mediation effect averaged about 1% of the total treatment effect across the three 
samples. The 95% confidence interval of the mean mediation effect included zero in all 
samples. The mediation hypothesis was not confirmed. 
 
Table 4: Testing the mediation effect according to the Bootstrap approach. 
 
 
 
Prins 
 
Knoop 
 
Stulemeijer 
 
mean mediation effect 
Lower CI (95%) 
Upper CI (95%) 
% total treatment effect 
 
-0.03 
-0.39 
0.27 
0.5 
 
0.01 
-0.69 
0.76 
-0.15 
 
-0.61 
-2.19 
0.86 
3.2 
 
DISCUSSION 
The data did not support a treatment model in which the effect of CBT on fatigue is mediated 
by an increase in physical activity. CBT did neither cause an increase in physical activity at 
the end of treatment (path a) nor was an increase in physical activity associated with a 
reduction in fatigue (path b). A formal test of the mediation effect confirmed that CBT 
yielded its effect independent of a persistent change in physical activity. 
These results are in line with the study of Moss-Morris et al. (2005) in which was 
demonstrated that not an increase in fitness but a change in preoccupation with symptoms 
mediated the effect of GET on fatigue. The results are also consistent with earlier research on 
CBT for CFS in which a reduction in fatigue was associated with a change in illness beliefs 
(Deale et al.,1998). In the light of these findings, changing illness related cognitions seems to 
play a more crucial role in CBT for CFS than an increase in physical activity. 
There are several potential alternative explanations for the fact that we did not find 
support for our mediation hypothesis. A substantial amount of patients did not complete 
actigraphy at second assessment and had to be excluded from our mediation analyses. It is 
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possible that we introduced a bias through exclusion which might account for our findings. 
However, analysis of the baseline characteristics revealed that a selection bias is no likely 
explanation for our findings. 
Our patients were not required to stick to their physical activity program until the end of 
therapy. As treatment proceeded, they were allowed to substitute physical activities for other 
activities such as social ones. Consistently, treatment could have resulted in a temporary 
increase in physical activity which was no longer existent when second assessment took 
place. This temporary increase in physical activity during treatment might have been 
sufficient to facilitate a persistent change in illness related cognitions. When patients learned 
that they were able to increase their level of physical activity despite of their symptoms, their 
believe of having little control over their condition should have changed and with it also the 
perception of fatigue as an inherently aversive state. To examine these mechanisms of change 
in CBT for CFS, patients’ physical activity and illness related cognitions need to be 
monitored repeatedly during treatment. 
Patients with a pervasively passive activity pattern have extremely low levels of physical 
activity. These patients do not respond to common CBT for CFS (Prins et al., 2001). A 
specifically tailored approach in which the physical activity program is delivered earlier 
showed better effects for these patients (e.g. Stulemeijer et al., 2005). They might thus profit 
from a persistent increase in physical activity after all. Unfortunately, the number of patients 
was too small to properly examine whether a change in physical activity does mediate the 
effect of treatment in pervasively passive patients. 
In contrast to pervasively passive patients, the majority of CFS patients is not only 
characterised by a low level of physical activity, but has also a deregulated pattern of physical 
activity in which short periods of high activity are alternated with longer periods of rest (van 
der Werf et al., 2000). These patients were taught to spread their activities evenly across day 
and week (Bleijenberg et al., 2003). Perhaps a change in activity regulation is more important 
to facilitate improvement in relatively active CFS patients than an increase in physical 
activity. 
Taking these considerations into account, the exact role of physical activity in CBT for 
CFS remains to be determined. Besides physical activity, future investigations should also 
examine the role of changes in social, mental and work related activities in CBT for CFS, 
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preferably based on the time patients actually spend on these activities to limit perception 
bias. For the time being, our study was the first one to show that the severity of fatigue in 
patients with CFS is not reduced by CBT because patients have become more physically 
active at the end of their treatment. Based on these findings, physical activity programs can 
better be understood as a way to facilitate change in other mechanisms which are more 
directly related to a change in fatigue. Among these mechanisms, a change in illness related 
cognitions is likely to play a crucial role in CBT for CFS and should therefore be monitored 
closely during treatment. 
32 
REFERENCES 
Baron RM, Kenny DA. (1986). The moderator-mediator variable distinction in social psychological research:   
   conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology 51, 1173-82. 
Black CD, O'Connor PJ, McCully KK. (2005). Increased daily physical activity and fatigue symptoms in chronic  
   fatigue syndrome. Dynamic Medicine 4. Doi:10.1186/1476-5918-4-3 
Bleijenberg G, Prins JB, Bazelmans E. (2003). Cognitive-behavioral therapies. In Handbook of Chronic  
   Fatigue Syndrome (ed. L. A. Jason, P. A. Fennell and R. R. Taylor), pp. 493–526. Wiley: New York. 
Chambers D, Bagnall AM, Hempel S, Forbes C. (2006). Interventions for the treatment, management  
   and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated   
   systematic review. Journal of the Royal Society of Medicine 99, 506-20. 
Deale A, Chalder T, Marks I, Wessely S. (1997). Cognitive behavior therapy for chronic fatigue  
   syndrome: a randomized controlled trial. American Journal of Psychiatry 154, 408-14. 
Deale, A, Chalder, T, Wessely, S. (1998). Illness beliefs and treatment outcome in chronic  
   fatigue syndrome. Journal of Psychosomatic Research 45, 77-83. 
Dittner, AJ, Wessely, S, & Brown, RG. (2004). The assessment of fatigue: a practical guide for clinicians  
   and researchers. Journal of Psychosomatic Research 56, 157-70. 
Edmonds M, McGuire H, Price J. (2004). Exercise therapy for chronic fatigue syndrome. Cochrane  
   Database of Systematic Reviews, 3. DOI: 10.1002/14651858.CD003200.pub2.  
Frazier PA, Tix AP, Barron KE. (2004). Testing moderator and mediator effects in counseling psychology  
   research. Journal of Counseling Psychology 51, 115-134.  
Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. (1994). The chronic fatigue   
   syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome  
   Study Group. Annals of Internal Medicine 121, 953-9. 
Fulcher KY, White PD. (1997). Randomised controlled trial of graded exercise in patients with  
   the chronic fatigue syndrome. British Medical Journal 314, 1647-52. 
Knoop H, van der Meer JW, Bleijenberg G. (2008). Guided self-instructions for people with chronic    
   fatigue syndrome: randomised controlled trial. British Journal of Psychiatry 193, 340-1. 
Malouff JM, Thorsteinsson EB, Rooke SE, Bhullar N, Schutte NS. (2008). Efficacy of cognitive  
   behavioral therapy for chronic fatigue syndrome: a meta-analysis. Clinical Psychology Review 28, 736-45. 
Moss-Morris R, Sharon C, Tobin R, Baldi JC. (2005). A randomized controlled graded exercise trial for  
   chronic fatigue syndrome: outcomes and mechanisms of change. Journal of Health Psychology 10, 245-59. 
Preacher KJ, Hayes AF. (2004). SPSS and SAS procedures for estimating indirect effects in  
   simple mediation models. Behavior Research Methods, Instruments, & Computers 36, 717-31. 
Price JR, Mitchell E, Tidy E, Hunot V. (2008). Cognitive behaviour therapy for chronic fatigue syndrome  
   in adults. Cochrane Database of Systematic Reviews 3. DOI:10.1002/14651858. CD001027.pub2. 
Prins JB, Bleijenberg G, Bazelmans E, Elving LD, de Boo TM, Severens JL, van der Wilt GJ,  
   Spinhoven P, van der Meer JW. (2001). Cognitive behaviour therapy for chronic fatigue syndrome: a  
   multicentre randomised controlled trial. Lancet 357, 841-7. 
Quarmby L, Rimes KA, Deale A, Wessely S, Chalder T. (2007). Cognitive-behaviour therapy for   
   chronic fatigue syndrome: comparison of outcomes within and outside the confines of a randomised   
   controlled trial. Behaviour research and therapy 45, 1085-94. 
Sharpe M, Hawton K, Simkin S, Surawy C, Hackmann A, Klimes I, Peto T, Warrell D, Seagroatt V. (1996).  
   Cognitive behaviour therapy for the chronic fatigue syndrome: a randomized controlled trial. British Medical  
   Journal 312, 22-6. 
Stulemeijer M, de Jong LW, Fiselier TJ, Hoogveld SW, Bleijenberg G. (2005). Cognitive behaviour  
   therapy for adolescents with chronic fatigue syndrome: randomised controlled trial. British Medical  
   Journal 330. Doi:10.1136/bmj.38301.587106.63. 
Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. (1994).  
   Dimensional assessment of chronic fatigue syndrome. Journal of Psychosomatic Research 38, 383-92. 
Vercoulen JH, Swanink CM, Galama JM, Fennis JF, Jongen PJ, Hommes OR, van der Meer JW,      
   Bleijenberg G. (1998). The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis:  
   development of a model. Journal of Psychosomatic Research 45, 507-17. 
Wearden AJ, Morriss RK, Mullis R, Strickland PL, Pearson DJ, Appleby L, Campbell IT,  
   Morris JA. (1998). Randomised, double-blind, placebo-controlled treatment trial of fluoxetine  
   and graded exercise for chronic fatigue syndrome. British Journal of Psychiatry 172, 485-90.  
 
33 
van der Werf SP, Prins JB, Vercoulen JH, van der Meer JW, Bleijenberg G. (2000). Identifying  
   physical activity patterns in chronic fatigue syndrome using actigraphic assessment. Journal of  
   Psychosomatic Research 49, 373-9. 
  
 
 3 
 
 
 
 
 
 
 
 
 
 
Does a decrease in avoidance behaviour and focusing on fatigue mediate the 
effect of cognitive behaviour therapy for chronic fatigue syndrome? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Jan F Wiborg, Hans Knoop,  Judith B Prins & Gijs Bleijenberg 
Journal of Psychosomatic Research 2011; 70: 306-310
36 
ABSTRACT 
Cognitive behaviour therapy (CBT) leads to a significant reduction in fatigue severity and 
impairment in patients with chronic fatigue syndrome (CFS). The purpose of the present study 
was to determine whether the effect of CBT for CFS on fatigue and impairment is mediated 
by a decrease in avoidance behaviour and focusing on fatigue. For this purpose, we 
reanalysed a randomised controlled trial which was previously conducted to test the efficacy 
of CBT for CFS. Two-hundred nineteen patients completed assessment prior and subsequent 
to treatment or a control group period. Mediation analysis revealed that a decrease in focusing 
on fatigue mediated the effect of CBT for CFS on fatigue and impairment. Avoidance of 
activity and avoidance of aversive stimuli were not significantly changed by treatment and 
were therefore excluded from mediation analysis. A decrease in the focus on fatigue seems to 
contribute to the treatment effect of CBT for CFS. 
37 
INTRODUCTION 
Chronic fatigue syndrome (CFS) is characterised by severe and disabling fatigue which 
persists at least six months and which is not the result of a medical condition or ongoing 
exertion (Fukuda et al., 1994). Additional symptoms such as pain, concentration problems and 
postexertional malaise are frequently reported. According to the cognitive behavioural model 
for CFS (Surawy et al., 1995; Prins et al., 2006), patients fail to cope adequately with a period 
of somatic illness or psychological stress which causes the perpetuation of their symptoms. 
For example, Vercoulen et al. (1998) found that CFS patients who believe that their 
symptoms are due to an ongoing medical condition are also more likely to engage in less 
physical activity which was associated with higher levels of fatigue and impairment. Other 
factors which contributed to higher levels of symptomatology in their model of perpetuating 
factors were higher levels on focusing on symptoms and lower levels on sense of control over 
the complaints. Cognitive behaviour therapy (CBT) intervenes in the perpetuating factors for 
CFS by gradually increasing the level of activity and systematically challenging illness-
related believes (Sharp et al., 1996; Deale et al., 1997; Bleijenberg et al., 2003). This strategy 
has been shown to be effective in reducing fatigue severity, impairment and additional 
complaints in CFS patients (Malouff et al., 2008; Price et al., 2008).  
Despite the fact that CBT for CFS is by now an evidence-based intervention, it is not yet 
well understood through which mechanisms of change this intervention works. Deale et al. 
(1998) found that good outcome in CBT for CFS is associated with less avoidance behaviour 
but not with less somatic attributions. Whether the effect of the intervention was actually 
mediated by a decrease in avoidance behaviour was not tested in this study. Mediation is the 
process in which one or more variables (the hypothesised mediators) intervene in the 
relationship between treatment en outcome (Baron & Kenny, 1986; Frazier et al., 2004). In 
mediation analysis, the mechanisms of change of psychological interventions are identified. 
This analytic strategy can substantially contribute to the validation of treatment models and 
the enhancement of clinical practice (Kraemer et al., 2002). 
Moss-Morris et al. (2005) conducted a mediation analysis in which the mechanisms of 
change in graded exercise therapy (GET) were analysed. GET for CFS is a behavioural 
intervention in which patients gradually increase their level of fitness, for example on exercise 
bikes. Illness beliefs are not challenged explicitly. Their mediation analyses showed that GET 
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did not lead to the hypothesised increase in physical fitness but a decrease in the focus on 
symptoms which mediated the effect of their intervention. Similarly, Wiborg et al. (2010) 
were unable to find a persistent increase in physical activity in three randomised controlled 
trials (RCTs) of CBT for CFS. 
In the present study, we were interested in whether decreases in avoidance behaviour and 
focusing on symptoms might mediate the effect of CBT for CFS. For this purpose, we 
reanalysed a RCT which was previously conducted by our research group to test the efficacy 
of CBT for CFS (Prins et al., 2001). The intervention was based on the CBT for CFS manual 
described by Bleijenberg et al. (2003) and was more effective in reducing fatigue severity and 
impairment than two control group conditions. We hypothesised that a decrease in avoidance 
behaviour and focusing on fatigue would mediate the effect of our intervention.                
 
METHODS 
Sample 
In total, 270 patients were randomly assigned to either CBT or one of two control group 
conditions. CBT consisted of 16 one-hour sessions spread over a period of 8 months. In the 
first control group, patients received 11 one-and-a-half-hour meetings of non-directive 
counselling spread over a period of 8 months. In the second control group, patients received 
no intervention and were free to do whatever they found appropriate. The results of the two 
control groups were similar in the original trial (Prins et al., 2001). We therefore approached 
the two control groups as one in our analyses (see also Wiborg et al., 2010). 
All groups were assessed before treatment or the control group period had started 
(baseline), 8 months later when treatment or the control group period had been finished 
(second assessment) and at 6 months follow-up (i.e. 14 months after baseline assessment). In 
the present study, we concentrated on the mechanisms of change between baseline and second 
assessment which was accomplished at the end of treatment. Fifty-one patients did not 
complete second assessment of the coping strategies and were excluded from the present 
study. The mean age of the remaining 219 patients was 36.9 years (SD= 10.2) and 79% of 
them was female. The mean illness duration was 5.5 years (SD= 5.5). All patients met the 
CDC research criteria for CFS (Fukuda et al., 1994), except for fourteen patients who did not 
have four or more additional symptoms. 
39 
Instruments 
Coping Strategies: We modified the Pain Coping Inventory (Kraaimaat & Evers, 2003) by 
substituting the word fatigue for pain and selected all items of the second order factor passive 
coping, which reflects the tendency to restrict functioning and think negative about the 
symptoms (table 1). 
 
Table 1: The validation of avoidance behaviour and focusing on fatigue (N=267). 
 
factor 
 
When I feel fatigued I ... 
 
loading 
 
avoidance of  
activity 
 
(α = 0.72) 
 
...stop with my activities. 
...confine myself to simple activity 
...do not exert myself physically. 
...rest, sitting or lying down. 
...take a comfortable posture. 
 
.56 
.60 
.74 
.73 
.63 
avoidance of  
aversive stimuli 
 
(α = 0.73) 
...make sure that I do not get upset. 
...search for a restful environment to retreat. 
...avoid bothering sounds. 
...avoid light. 
...am careful of what I eat or drink. 
...separate myself.  
...try to return home as soon as possible. 
.43 
.72 
.69 
.58 
.48 
.65 
.58 
 
focusing  
on fatigue 
 
(α = 0.80) 
 
...focus on the fatigue all the time. 
...think of all the things that remain undone because of the fatigue. 
...start to worry. 
...wonder about the cause of the fatigue. 
...think that the fatigue will get worse. 
...think about moments which were free from fatigue. 
...think I will go mad because of the fatigue. 
...think that others do not understand what it is to have such fatigue. 
 
.59 
.72 
.76 
     .74 
.67 
.59 
.49 
.45 
Note. Only loadings of >.40 are shown. 
 
Because this modification has not been validated before, we conducted a Principal 
Component Analysis (PCA) in our sample resulting in three independent factors which were 
named avoidance of activity, avoidance of aversive stimuli, and focusing on fatigue (table 1). 
This structure is identical with the findings of Kraaimaat et al. (2003), with the exception of 
one item (the self-administration of physical stimuli) which was excluded because it did not 
load substantially on any of our factors (i.e. <.40). 
All items were scored on a 4-point Likert scale varying between 1, seldom or never, and 
4, very often. Higher sum scores indicated more avoidance of activity, avoidance of aversive 
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stimuli and focusing on fatigue. The sum scores on the individual scales vary between 5 and 
20 in the case of avoidance of activity (5 items), 7 and 28 in the case of avoidance of aversive 
stimuli (7 items) and 8 and 32 in the case of focusing on fatigue (8 items). The internal 
consistency of the individual scales was satisfactory (table 1). All three factors were 
significantly related to each other (table 2). 
 
 Table 2: Pearson’s correlation coefficients (N=267). 
 
 
avoidance 
of activity 
 
avoidance of 
aversive stimuli 
 
avoidance of   
aversive stimuli 
 
 
.42 
 
focusing on  
symptoms 
 
.20 
 
.26 
Note. All coefficients were significant at p<.001. 
 
Fatigue: The subscale fatigue severity of the Checklist Individual Strength (CIS) was used to 
indicate the level of fatigue during the last two weeks. All items of the CIS were scored on a 
7-point Likert scale. The sum score of the subscale fatigue severity (8 items) varies between 
8, no fatigue, and 56, severe fatigue. The CIS is a reliable and valid instrument which has 
been shown to be sensitive for changes over time (Vercoulen et al., 1994). The internal 
consistency of the fatigue severity subscale has been found to be good with a Cronbach’s 
alpha of 0.88. The cut-off score for severe fatigue was 40 or higher in this study. 
 
Impairment: The level of impairment was measured with the Sickness Impact Profile 
(Bergner et al., 1981) which has good reliability and content validity. A total score was 
calculated by addition of the weights of items (range 0–5799) in eight subscales: home 
management, mobility, alertness behaviour, sleep/rest, ambulation, social interactions, work, 
and recreation (Prins et al., 2001).  
 
Analyses 
We conducted two multivariate general linear models (GLM) to test the differences at 
baseline assessment between included versus excluded patients and to test whether treatment 
actually changed the coping strategies of our patients. To correct for type I errors (i.e. 
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incorrect rejection of true null hypotheses), we only took significant differences on the 
univariate tests into account when the multivariate test yielded significance as well. Following 
the widely accepted standard of Baron et al. (1986) for mediation analysis, we excluded all 
coping strategies from further analysis which were not significantly affected by CBT 
according to our GLM.  
A macro extension for SPSS introduced by Preacher and Hayes (2004) was used to test 
our mediation hypotheses. At first, the effect of treatment on outcome was tested (a). Second, 
the effect of treatment on the hypothesised mediator was tested (b). Third, the effect of the 
hypothesised mediator on outcome was tested, corrected for treatment (c). Thereafter, the 
effect of treatment on outcome was tested again, this time corrected for the hypothesised 
mediator (a’). If all of these effects, including a’, were significant all preconditions for partial 
mediation were fulfilled (Baron et al., 1986). If all of these effects, except path a’, were 
significant all preconditions for complete mediation were met. All of these tests were 
conducted using regression analysis. Change scores (second minus baseline assessment) were 
used for all outcome and mediator variables. 
A non-parametric bootstrap approach was used to estimate the extent to which the effect 
of our intervention was actually mediated by a change in coping and to test for the statistical 
significance of the mediation effect (Preacher et al., 2004). In the bootstrap approach, 
population parameters are generated empirically instead of relying on normal theory. This 
approach leads to more power to detect significant effects even in small, non-normally 
distributed samples. A mean mediation effect with a 95% confidence interval was generated 
by randomly resampling the observed dataset 1000 times with replacement. The null 
hypothesis was rejected when this 95% confidence interval did not include zero. This 
procedure equals the p < .05 standard in normal theory testing which was used as threshold 
for significant findings in the multivariate GLM’s as well. 
 
RESULTS 
Differences on baseline assessment due to exclusion 
Multivariate testing of the baseline differences on fatigue, impairment and coping due to 
exclusion did not yield significance (table 3). Univariate differences were therefore not further 
tested. 
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Table 3: Testing the mean differences at baseline assessment on fatigue,  
impairment, and coping due to exclusion. 
Note. Three excluded patients did not complete baseline assessment as well. 
 
Selecting potential mediators of the treatment effect of CBT for CFS 
The multivariate test of the treatment effect on changes in coping was significant (table 4). 
Univariate testing revealed that the focus on fatigue decreased significantly more in the 
treatment group than in the control group. The effect of treatment on avoidance of activity and 
avoidance of aversive stimuli was not significant. Avoidance behaviour was therefore 
excluded from further analyses. 
 
 Table 4: Testing the effect of treatment (CBT vs. control) on changes in coping (SD) (N=219).  
 
 
treatment 
 
control 
 
F 
 
p 
 
multivariate 
 
  
 
 
 
 
   Wilks-Lambda  0.94 4.40 .005 
univariate     
   Δ avoidance of activity -0.5 (2.5) -0.4 (2.3) 0.09 .762 
   Δ avoidance of stimuli -1.0 (3.8) -0.6 (3.2) 0.94 .333 
   Δ focusing on fatigue -3.2 (3.6) -1.4 (3.3) 13.0 <.001 
 
Testing the mediation effect of changes in focusing on fatigue 
Analysis of the effects a, b, c, and a’ showed that all conditions for partial mediation were met 
in the case of fatigue (figure 1). In the case of impairment, all conditions for complete 
mediation were met (figure 2). According to the bootstrap approach, the mean mediation 
effect on fatigue was -0.74 with a lower confidence interval of -1.89 and an upper confidence 
interval of -0.08. The effect of treatment on fatigue was significantly mediated by a decrease 
in focusing on fatigue. The same accounted for the mean mediation effect on impairment 
which was -67.92, with a lower confidence interval of -165.45 and an upper confidence 
interval of -21.01.  
 
 
included 
 
excluded 
 
F 
 
p 
 
n  (CBT) 
 
219 (73) 
 
51 (19) 
 
 
 
 
multivariate    
   Wilks-Lambda  0.97 1.72 .131 
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Figure 1: Regression coefficients as derived with the macro of Preacher & Hayes for fatigue (the value in 
parentheses represents the effect of CBT on fatigue without correction for the mediator). 
 
 
 
 
 
   
                             -1.8
***
                                  0.4
* 
 
 
 
                                                              
                                         -5.9
***
 (-6.6
***
) 
 
 
Note. 
*
p< .05. 
**
p< .01. 
***
p< .001. All effects are unstandardised. 
 
 
Figure 2: Regression coefficients as derived with the macro of Preacher & Hayes for impairment (the value in 
parentheses represents the effect of CBT on impairment without correction for the mediator). 
 
 
 
 
 
   
                              -1.8
***
                                  38.6
** 
 
 
 
                                                              
                                        -115.1 (-183.1
*
) 
 
 
Note. 
*
p< .05. 
**
p< .01.
 **
p< .001. All effects are unstandardised. 
 
DISCUSSION 
The purpose of the present study was to determine whether the treatment effect of CBT for 
CFS is mediated by a decrease in avoidance behaviour and focusing on fatigue. As 
hypothesised, we found support in favour of a treatment model in which the level of fatigue 
and impairment were reduced because patients had decreased their focus on fatigue. This 
finding is in line with a study conducted by Moss-Morris et al. (2005) in which a change in 
focusing on symptoms mediated the effect of GET for CFS. To our knowledge, our study is 
 
CBT 
 
Δ fatigue 
 
 
CBT 
 
Δ impairment 
 
 
Δ focus on fatigue 
 
 
 
Δ focus on fatigue 
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the first one to show that a decrease in the focus on fatigue also contributes to the reduction of 
fatigue and impairment in CBT for CFS.  
This finding is also in accordance with a recent review in which we argued that cognitive 
processes are likely to play a central role in the perpetuation and treatment of CFS (Knoop et 
al., 2010). One of these processes is the tendency to focus on the fatigue. In CFS patients, this 
tendency could be a difficulty to disengage from the symptoms which is also seen in 
depressive disorders in the form of rumination (Caseras et al., 2007). However, it might also 
be a form of hypervigilance which is a state of abnormally increased arousal and 
responsiveness to certain stimuli also found in anxiety disorders (Caseras et al., 2008). An 
inspection of the factor loadings of our focusing scale suggests that we have primarily tested 
the ruminative character of this concept. More research is needed to unravel the exact nature 
of the focus on symptoms in CFS patients, including methods which assess attentional 
processes experimentally (Knoop et al., 2010). 
Contrary to our hypothesis that a decrease in avoidance of activity and aversive stimuli 
would also mediate the effect of our intervention, we found no significant effect of treatment 
on avoidance behaviour. Several explanations may account for this finding which can also be 
understood as limitations of our study. First, we simply may have missed a temporary change 
in avoidance behaviour because we had no assessment during treatment. Such a temporary 
change might have been sufficient to facilitate improvement and may have been no longer 
relevant once the level of fatigue had been decreased. Advanced data about the mediating 
variables while treatment is proceeding are needed to enhance the understanding of the exact 
sequences of change in CBT for CFS.  
Next, we did not differentiate between patients with a fluctuating active and patients with 
a pervasively passive activity pattern (van der Werf et al., 2000). Fluctuating active patients 
are characterised by bursts of activity which are followed by periods of prolonged rest. 
Pervasively passive patients are characterised by low levels of physical activity on virtually 
all days. Avoidance behaviour may be more problematic in pervasively passive patients 
because they are more likely to fear that even moderate levels of activity can cause damage to 
their body. More research with higher numbers of these patients is needed to test whether they 
may actually profit from a reduction in avoidance behaviour. 
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Some more comment on our instrumentation seems appropriate as we used a coping inventory 
which has not been validated outside pain studies before. Although the factor structure of the 
scale appeared to be robust, we know little about how it relates to other fatigue related 
constructs. Furthermore, our focusing on fatigue scale seems to include items of other 
cognitive processes such as catastrophising (i.e. I think that I will go mad because of the 
fatigue). These concepts should be examined separately to further differentiate between the 
various cognitive processes which are supposed to play a role in CBT for CFS. Besides the 
before mentioned processes, promising candidates for a mediating effect between treatment 
and outcome are (changes in) a low self-efficacy with respect to the fatigue and dysfunctional 
beliefs about one’s own ability to be active (Knoop et al., 2010).  
Finally, clinical practice has been refined since our trial has been conducted about ten 
years ago which may limit the generalisability of our findings with respect to present 
cognitive behavioural interventions for CFS. For example, we modified our  treatment manual 
in order to be more responsive to pervasively passive patients who responded poorly to 
treatment in this trial. This modification has brought an increase in treatment effect 
(Stulemeijer et al., 2005). Hence, the active ingredients of CBT for pervasively passive CFS 
patients might be more adequately addressed in recent trials. Yet, independent of these and 
other considerations, we do not expect that the central mechanisms of change at work in CBT 
for CFS have changed fundamentally over time. 
In summary, our findings provide first support for the idea that CBT for CFS can profit 
from interventions which target the focus on symptoms. In treatment, patients should learn to 
accept prevalent feelings of fatigue and train their ability to distract their attention from their 
complaints to facilitate improvement, for example by focusing on activity or aspects of the 
environment. Our findings may also implicate that continuous registration of the complaints 
can be disadvantageous because patients are encouraged to focus on their symptoms. 
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ABSTRACT 
The purpose of the present study was to develop a treatment model for cognitive behavioural 
interventions focusing on chronic fatigue syndrome (CFS) based on the model of perpetuating 
factors. For this purpose, we reanalysed the data of a previously conducted randomised 
controlled trial in which a low intensity cognitive behavioural intervention was compared to a 
waiting list control group. Structural equation modelling was used to test a treatment model in 
which changes in focusing on symptoms, perceived problems with activity, and sense of 
control over fatigue were hypothesised to mediate the effect of our intervention on fatigue 
severity and disability. In the final model, which had a good fit to the data, the effect of 
treatment was mediated by a decrease in perceived problems with activity and an increase in 
sense of control over fatigue. Our findings suggest that cognitive behavioural interventions 
for CFS need to change the illness perception and beliefs of their patients in order to be 
effective. 
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INTRODUCTION 
Chronic fatigue syndrome (CFS) is characterised by severe and disabling fatigue which 
persists at least six months and which cannot be explained medically (Fukuda et al., 1994). 
Cognitive behavioural interventions have been shown to be effective in reducing the 
symptomatology of CFS patients (Malouff et al., 2008; Price et al., 2008). These interventions 
usually incorporate a program in which the level of activity is gradually increased while 
dysfunctional beliefs are systematically challenged (Sharp et al., 1996; Deale et al., 1997; 
Bleijenberg et al., 2003; Quarmby et al., 2007). It is a widely accepted premise that the 
treatment effect of these interventions can be attributed to these ingredients, but empirical 
studies on the exact mechanisms of change are scarce and typically limited to the validation 
of one active ingredient per study. The purpose of the present study was to develop a more 
comprehensive model for cognitive behavioural interventions focusing on CFS. 
 Different cognitive behavioural models exist that seek to explain the persistence of 
symptomatology in CFS patients (Wessely et al., 1989; Surawy et al., 1995; Fry& Martin, 
1996; Vercoulen et al., 1998; Gaab, 2004). All of these approaches generally agree on the fact 
that illness-specific beliefs and behaviours perpetuate the suffering of these patients and that 
effective treatment needs to intervene in the perpetuating factors to facilitate improvement. In 
figure 1, we present the work of Vercoulen et al. (1998), who introduced an empirically 
supported model of perpetuating factors for CFS. This model served as basis for the 
development of our treatment model. In the model of Vercoulen et al. (1998), a combination 
of being physically inactive, lacking sense of control over fatigue and focusing on symptoms 
perpetuates severe fatigue and impairment. The low level of physical activity is caused by 
predominant somatic attributions.  
 
Figure 1: Model of perpetuating factors introduced by Vercoulen et al. (1998). 
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Several studies have tested the role of these perpetuating factors in facilitating improvement. 
A study by Deale et al. (1998) showed that somatic attributions of CFS patients are not 
affected by cognitive behaviour therapy (CBT). Without such a change, a factor cannot 
account for the effect of treatment (Baron & Kenny, 1986; Frazier et al., 2004). This finding 
is also in accordance with the model of perpetuating factors in which causal attributions are 
not directly linked to fatigue or impairment (Vercoulen et al., 1998). Consequently, we 
excluded this variable from further examination. 
 The role of activity is more complex. In the model of Vercoulen et al. (1998), the 
persistence of fatigue and impairment is caused by a low level of physical activity which 
suggests that patients need to get physically more active in order to improve. Two studies 
tested this hypothesis. Moss-Morris et al. (2005) examined whether the effect of graded 
exercise therapy (GET) can be explained by a change in physical fitness. Although patients 
gradually increased their level of physical activity on exercise equipment in this study, the 
treatment effect was not mediated by a change in physical fitness. In the second study, 
Wiborg et al. (2010) examined three randomised controlled trials (RCTs) to test whether the 
effect of CBT for CFS can be explained by an increase in Actometer scores. Actometers are 
motion sensing devices which are frequently used to assess physical activity in CFS patients. 
They found that the effect of treatment was not mediated by a change in these scores. In other 
words, an increase in physical activity was not responsible for the treatment effect in any of 
these studies.  
It is vital to notice in this context that Vercoulen et al. (1998) assessed physical activity 
with self-rating scales in their model of perpetuating factors which are known to be receptive 
to cognitive biases. Knoop et al. (2010) have argued that such biases are central to the 
perpetuation of CFS. In particular, patients with CFS tend to perceive substantial problems 
with activity independent of their objective performance and interpret these problems as 
inherent feature of an uncontrollable illness. A change in perceived problems with activity 
through activity programs may, in turn, correct the belief that CFS is an uncontrollable illness 
and thereby help to relieve symptomatology. This would also be in accordance with a study 
by Deale et al. (1998), who found that a change in activity-related beliefs was associated with 
improvement in CBT for CFS. 
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To our knowledge no comparable study has been conducted with control-related beliefs in the 
context of CFS, but an increase in sense of control has been shown to be a powerful mediator 
of the treatment effect of CBT for chronic pain (Turner et al, 2007). A comparable finding in 
the context of CFS would be in accordance with the model of perpetuating factors (Vercoulen 
et al., 1998), which suggests that an increase in sense of control over fatigue should lead to 
lower levels of fatigue.  
The remaining factor of the Vercoulen et al. (1998) model is focusing on symptoms. Two 
mediation studies examined the role of this factor, one in GET for CFS (Moss-Morris et al., 
2005) and one in CBT for CFS (Wiborg et al, 2011). A decrease in focusing on symptoms 
was a significant mediator of the treatment effect in both studies.  
Based on these insights, we included focusing on symptoms, perceived (i.e. self-reported) 
problems with activity, and sense of control over fatigue into our search for a more 
comprehensive treatment model for cognitive behavioural interventions focusing on CFS. We 
reanalysed the most recent of the RCTs that were examined in the study by Wiborg et al. 
(2010) for this purpose. The original study was conducted by Knoop et al. (2008) and 
compared a low intensity cognitive behavioural intervention with a waiting list control group. 
Levels of fatigue severity and disability were significantly decreased by this intervention.  
 
METHODS 
Sample and Intervention 
For a detailed description of the original trial we refer the reader to Knoop et al. (2008). In the 
present study, 30 of the 169 patients that were included in the original trial were excluded 
because they did not complete the second assessment of the hypothesised mediators (see also 
Wiborg et al., 2010). The mean age of the remaining 139 patients was 37.8 years (SD = 10.4). 
The median illness duration was 7 years, with a minimum of 1 and a maximum of 35 years. 
One hundred and eight patients (78%) were female. Sixty-four patients (46%) received the 
guided self-instructions. Treatment was delivered in accordance with the manual of 
Bleijenberg et al. (2003) which was based on the model of perpetuating factors discussed 
earlier (Vercoulen et al., 1998). Instead of face-to-face contact, the intervention relied on 
written self-instructions combined with e-mail contact with a trained therapist. The 
intervention included goal setting, fixed sleep wake cycles, reducing the focus on bodily 
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symptoms, the systematic challenge of fatigue-related beliefs, the regulation and gradual 
increase of activity, and the accomplishment of personalised goals. 
 
Instruments 
Fatigue: The subscale fatigue severity from the Checklist Individual Strength (CIS) was used 
to measure the level of fatigue in our patients. It consists of eight items which are scored on a 
7-point Likert scale. The sum score varies between 8, no fatigue, and 56, extremely severe 
fatigue. The cut-off score for severe fatigue used in this study was 35 (or higher). The CIS is a 
reliable and valid instrument for the assessment of fatigue in CFS patients (Vercoulen et al., 
1994; Dittner et al., 2004). The Cronbach’s alpha reliability coefficient for the fatigue severity 
subscale is 0.88 (Vercoulen et al., 1994).   
 
Disability: The level of disability was measured with two instruments. Both instruments 
assess aspects of the effect of CFS on daily functioning and were used as primary outcome 
measures in the original trial of Knoop et al. (2008). The physical functioning subscale from 
the 36-item Short Form Health Survey (SF-36) was used to measure physical disability 
(Stewart et al., 1988). The scores on this scale range from 0, maximal limitations, to 100, no 
limitations at all. The Sickness Impact Profile (SIP) was used to assess overall impairment in 
eight different areas (Bergner et al., 1981). A sum score was computed using the subscales 
home management, ambulation, mobility, alertness behaviour, social interactions, sleep/rest, 
recreation, and work (Prins et al., 2001). Higher scores indicate more overall impairment. 
 
Focus on symptoms: We used the somatic complaints subscale of the Symptom Checklist 90 
(SCL-90) (Arindell & Ettema, 1986) to assess focusing on symptoms. Following Vercoulen et 
al. (1998), higher scores on this scale indicate a stronger focus on symptoms. 
 
Perceived problems with activity: We used the activity subscale of the Checklist Individual 
Strength (CIS) to assess perceived problems with activity in our patients. The scale has 3 
items which are scored on a 7-point Likert scale (e.g. “I don’t do much during the day”, “I 
have a low output in terms of activity”). The sum score on this scale varies between 3 and 21. 
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Higher scores on this scale indicate more problems with activity. The Cronbach’s alpha 
reliability coefficient for this subscale of the CIS is 0.87 (Vercoulen et al., 1994). 
 
Sense of control: The perceived level of control over fatigue was measured with the Self-
Efficacy Scale (SES). This scale consists of five items (e.g. “I think that I can influence my 
fatigue”, “I feel helpless against my fatigue”). Four of these items were scored on a 5-point 
and one item on a 4-point Likert scale. Higher scores on this scale indicate more sense of 
control over fatigue. The internal consistency of this scale ranges between .68 and .77 (Prins 
et al., 2001; de Vree et al., 2002). 
 
Analyses 
We conducted a multivariate general linear model (GLM) to test whether baseline scores of 
fatigue, disability, focusing on symptoms, perceived problems with activity, and sense of 
control differed between those patients who were excluded from our study due to missing data 
and those patients who were included. To correct for type I errors (i.e. incorrect rejection of 
true null hypotheses), we took only significant differences on the univariate tests into account 
when the multivariate test yielded significance as well. 
Structural Equation modelling (SPSS Amos, version 17) was employed to test the 
hypothesised treatment models using the maximum likelihood setting. Change scores (second 
minus baseline assessment) were used for all variables except for treatment which was entered 
as dichotomous (0/1) variable (Wiborg et al., 2010). All tests were conducted twice, once with 
physical functioning (SF-36) and once with overall impairment (SIP), because both disability 
scales were used as primary outcome measures in the original trial (Knoop et al.; 2008).The 
threshold for statistical significance was set at p<.05. 
We started with a simple model in which treatment caused a change in fatigue and 
disability. A significant effect on these variables guaranteed an effective intervention on the 
primary outcome measures. We then tested, one factor at a time, whether a change in focusing 
on symptoms, perceived problems with activity and sense of control over fatigue significantly 
mediated the effect of the intervention on fatigue and disability. Mediators of the treatment 
effect needed to be significantly associated with treatment as well as treatment outcome. 
Factors which did not meet this precondition were excluded from further analysis (Baron et 
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al., 1986; Frazier et al., 2004). The mean mediation effect was tested with bootstrap analyses 
in which the observed dataset was randomly resampled 1000 times to generate population 
parameters (Preacher & Hayes, 2004). Next, we integrated all significant mediators of the 
treatment effect into one model and optimised this model in a final step. A modification index 
(MI) of > 4 was used as threshold for introducing new pathways when they were also 
meaningful from a theoretical point of view. To control for potential confounders, we also 
tested the final model with gender, age, and illness duration as cause for mediators and 
treatment outcome. 
The fit of the models was tested following the recommendations of Buhi et al. (2007). 
We tested whether models actually fitted the data using the χ² statistics. Lower χ² values were 
preferred and p-values of >.05 indicated that the model did not have to be rejected. Due to 
limitations of the χ² statistics, we also report the comparative fit index (CFI) and the root 
mean square error of approximation (RMSEA). The CFI was used to show how much better 
the model fitted the data than a null model without common factors. The closer the CFI was to 
1.00, the more superior the model was to the null model. Values of 0.95 or higher indicated a 
good fit. The RMSEA was used to indicate how well the model approached the data, 
assuming that there is no perfect model. Simpler models with fewer parameters are rewarded 
by this index. RMSEA values of < 0.06 indicated a good fit of the model (Hu & Bentler, 
1999). RMSEA values between > 0.06  and < 0.10 indicated a fit of the model that was still 
acceptable (Weston & Gore, 2006). P-values of >.05 confirmed that the RMSEA was not 
significantly higher than 0.10. 
 
RESULTS 
Multivariate testing showed no significant differences on baseline assessment of fatigue, 
disability, focusing on symptoms, perceived problems with activity, and sense of control 
between those patients who were excluded due to missing data and those patients who were 
included (table 1). Univariate differences on these variables were therefore not further tested.  
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Table 1: Testing the differences on mean baseline scores (SD) due to exclusion. 
 
 
 
 
 
 
 
 
In figures 2 and 3, we present the development of our treatment model. The fit of the different 
models is presented in table 2. All tests were conducted twice, once with physical functioning 
and once with overall impairment as disability measure. The test of model A confirmed that 
treatment significantly reduced the level of fatigue and disability in our selection of patients 
(figure 2). In models B-D, we tested one hypothesised mediator of the treatment effect at a 
time. The test of model B showed that treatment did not significantly affect the focus on 
symptoms in our patients. We therefore excluded this variable from further analysis. Testing 
models C and D revealed that a decrease in perceived problems with activity and an increase 
in sense of control over fatigue both significantly mediated the effect of our intervention 
(table 2). 
Although the model fit increased with the introduction of these variables when compared 
with the simple treatment model, the model fit was still inadequate. In particular, all models 
had to be rejected according to the χ² statistics. Some CFI values indicated that their models 
were substantially better than a null model but the RMSEA showed that these models still did 
not approach the data well enough. We therefore integrated both significant mediators of the 
treatment effect into model E which resulted in a substantial increase in mediation effect sizes 
but not in model fit. In a final step, we optimised our treatment model by excluding non-
significant pathways and introducing new conceptually meaningful pathways in accordance 
with the modification index (MI). The final model is depicted twice in figure 3, once for 
physical functioning and once for overall impairment.  
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F 
 
p 
 
 
n  (CBT) 
 
multivariate  
 
 
139 (64) 
 
 
30 (20) 
 
 
 
   Wilks-Lambda  0.97 0.82 .560 
 
 Figure 2: Developing a model for cognitive behavioural interventions focusing on chronic fatigue syndrome 
including standardised effects (β) derived with structural equation modelling (N=139). Each model is tested with 
physical functioning (left effects) as well as overall impairment (right effects) as measure for disability.  
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Table 2: Testing the fit of the various models, including analyses of the mediation effects (N=139). 
 
Model 
 
χ²  (df) 
 
p 
 
CFI 
 
RMSEA 
 
p 
 
SME 
 
% total 
effect
 
 
p 
 
A
1
 
A
2 
 
53.2 (1) 
18.4 (1) 
 
<.001 
<.001 
 
0.29 
0.67 
 
0.61 
0.36 
 
<.001 
<.001 
   
B
1
 
B
2
 
37.8 (1) 
  6.6 (1) 
<.001 
<.010  
0.64 
0.94 
0.52 
0.20 
<.001 
<.050 
   
C
1
 
 
C
2
 
39.8 (1) 
 
 5.1 (1) 
<.001 
 
<.010 
0.68 
 
0.96 
0.53 
 
0.17 
<.001 
 
  .051 
-.15
a 
 .10
b
 
-.13
c 
45 
42 
34 
<.010 
<.010 
<.010 
D
1
 
 
D
2
 
39.7 (1) 
 
11.1 (1) 
<.001 
 
<.001 
0.66 
 
0.89 
0.53 
 
0.27 
<.001 
 
 <.010 
-.13
a 
 .11
b
 
-.08
c 
39 
46 
21 
<.001 
<.001 
<.001 
E
1
 
 
E
2
 
40.9 (2) 
 
12.3 (2) 
<.001 
 
<.010 
0.76 
 
0.93 
0.38 
 
0.19 
<.001 
 
<.010 
 
-.23
a 
 .17
b 
-.17
c 
70 
71 
45 
<.001 
<.001 
<.001 
F
1 
   
F
2 
 2.0 (2) 
 
 4.7 (2) 
.360 
 
.096 
1.00 
 
0.98 
0.01 
 
0.10  
.476 
 
.175 
-.24
a 
 .18
b
 
-.17
c 
73 
75 
45 
<.001 
<.001 
<.001 
F
1* 
   
F
2* 
 4.4 (6) 
 
 7.2 (6) 
.622 
 
.306 
1.00 
 
1.00 
0.00 
 
0.04  
.783 
 
.510 
-.24
a 
 .16
b
 
-.16
c 
73 
67 
42 
<.001 
<.001 
<.001 
 
Note. 
1 
Model for physical functioning. 
2 
Model for overall impairment.
 
CFI: comparative fit index. 
RMSEA: root mean square error of approximation. SME: standardised mediation effects of treatment on 
fatigue
 a
, physical functioning
 b
, and overall impairment
 c
. Percentage total effect refers to the proportion of 
total treatment effect on treatment outcome that is explained by the mediators. 
* 
Controlling for the 
potential confounders gender, age, and illness duration. 
 
In both models of figure 3, the pathway between treatment and changes in fatigue was deleted 
because it was no longer significant with the mediators in the model (73% of the total 
treatment effect on fatigue was explained by the mediators). The same accounted for the 
pathway between treatment and changes in physical functioning (the mediators explained 
75% of the total treatment effect on physical functioning). In both models, a new pathway 
was introduced between changes in perceived problems with activity and changes in sense of 
control over fatigue. The modification index did not favour a direction for this effect (MI= 8.3 
for both directions in both models). Both solutions were also identical in terms of model fit. 
We favoured a pathway from changes in perceived activity to changes in sense of control 
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-.20
**
 
based on our understanding of CBT for CFS. In the physical functioning model, a pathway 
from changes in physical functioning to changes in fatigue was added for the same reason. 
This preference was in accordance with the modification index (MI= 22.9 as opposed to 18.2 
for the opposite direction). Both solutions were identical in terms of model fit.  
 
Figure 3: Testing the final optimised treatment model for physical functioning as well as overall impairment 
including the standardised effects (β) derived with structural equation modelling (N=139).  
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To control for potential confounders, we added gender, age, and illness duration to the model, 
hypothesising that these variables might influence mediators as well as treatment outcome. 
We were particularly interested in how robust our mediation effects would turn out to be 
under these circumstances. As shown in table 2, the mediation effects remained significant 
and largely unchanged. Interestingly, some fit indexes (in particular the RMSEA) profited 
from controlling for potential confounders. Both F models were accepted as the final 
treatment models. 
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DISCUSSION 
In the present study, we developed the first treatment model in the context of CFS which 
evaluates the contribution of more than one significant mediator of the treatment effect. We 
found that the effect of our intervention on fatigue, the central feature of CFS, remained 
significant until we integrated changes in perceived problems with activity and sense of 
control over fatigue into one model. The introduction of a pathway between the two mediators 
further enhanced the model. These findings may suggest that both mediators intertwine to 
reduce the symptomatology of CFS patients. 
Based on our understanding of CBT for CFS, we assumed that a perceived decrease in 
problems with activity might help to undermine the belief that the symptoms are 
uncontrollable and thereby facilitate a reduction in symptomatology. It is a major limitation of 
our study, though, that the mediators were not assessed while treatment was proceeding. This 
information would have contributed substantially to establishing causality among the factors 
of our model. This problem of temporality is also evident with respect to the outcome 
variables. We assumed that a reduction of reported physical dysfunction might precede a 
change in fatigue based on the prominent role of a graded activity program early in treatment 
(Bleijenberg et al., 2003). However, alternative models may also be plausible while fitting the 
data equally well. 
Our findings are in line with a number of other studies which found that evidence-based 
interventions for CFS may need to change the perception and beliefs of their patients in order 
to be successful (Deale et al., 1998; Moss-Morris et al., 2005; Wiborg et al., 2010; 2011). 
These findings are also in accordance with a recent study about chronic fatigue in multiple 
sclerosis which showed that the effect of CBT was mediated by a change in the perception of 
fatigue (Knoop et al., 2011). Based on these findings, CBT as well as GET therapists may 
want to deemphasise the role of physiological processes when they introduce the treatment 
rationale of their intervention to patients. In addition, they may want to systematically 
facilitate and monitor changes in cognitive processes that seem to be vital to successful 
treatment of CFS. These modifications might help to further enhance the generally moderate 
effects of evidence-based interventions for patients with CFS. 
Although all patients should profit from a change in illness perception, the group of 
pervasively passive patients may also need to get physically more active. This group is 
60 
characterised by an extremely low level of physical activity on almost all days. Such a pattern 
is particularly rare in healthy individuals and has led to an adaptation of the CBT for CFS 
manual introduced by Bleijenberg et al. (2003). The fact that the vast majority of CFS patients 
is relatively active might explain why increases in physical activity have not been found to 
play a role in the group as a whole (Wiborg et al., 2010). In future trials, the number of 
pervasively passive patients should be increased to conduct a separate test of the physical 
performance hypothesis for this subgroup. 
In contrast to what we expected, we had to exclude the focus on symptoms because it was 
not significantly changed by treatment. Even though we used the somatic complaints subscale 
of the SCL-90 in accordance with Vercoulen et al. (1998) to operationalise the process of 
focusing on symptoms, other scales may reflect this construct more accurately. Examples of 
such scales are the Illness Perception Questionnaire (Moss-Morris et al., 2005) and an 
adaptation of the Pain Coping Inventory (Wiborg et al., 2011) in which patients are 
interrogated about their preoccupation with symptoms. Another promising strategy in this 
context is the experimental assessment of attentional biases for fatigue-related information 
(Knoop et al., 2010). Unfortunately, none of these instruments were available in the trial of 
Knoop et al. (2008). 
There are further limitations to our study. We mentioned the problem of temporality due 
to simultaneous assessment of mediators and treatment outcome. This problem is particularly 
salient with respect to the relationship between changes in perceived problems with activity 
and fatigue severity because both scales stem from the same instrument (i.e. the Checklist 
Individual Strength). In addition, we assumed a priori that a change in all mediators should 
have the potential to affect all outcome variables. Although this idea was confirmed in models 
C and D, based on the model of Vercoulen et al. (1998) a link between changes in sense of 
control and disability should not have been introduced until the final optimisation of the 
treatment model. Furthermore, although we controlled the final model for gender, age and 
illness duration, other unmeasured variables may confound our mediation effects and thereby 
undermine the validity of our treatment model (Emsley et al., 2010). Finally, the validity of 
our findings might have also been affected by our compromise between “theory-driven” and 
“data-driven” techniques in the development of our treatment model. 
61 
In sum, a replication of our findings in prospective intervention studies is thus needed to 
validate our treatment model. This validation should be accomplished with studies that are 
primarily designed to examine treatment process. In such studies, change hypotheses can be 
generated beforehand based on the insights of the present study. Using alternative instruments 
for the assessment of focusing on fatigue and perceived problems with activity should thereby 
be considered. In addition, the process variables should be assessed repeatedly during 
treatment to enlighten the exact sequences of change and to help better understand the 
causality of the mutual relationships.  
 Although we deleted the direct effects of treatment on fatigue and physical functioning 
because they were no longer significant, the total treatment effect on outcome that was 
explained by our mediators did not exceed 75%. Additional mediators should therefore be 
added to the model. Besides the focus on symptoms, social support is a promising candidate, 
in particular in the context of overall impairment. Both, too little as well as too much support 
has been shown to contribute to the persistence of CFS (Prins et al., 2004). Less extreme 
scores on this variable may therefore be of potential value for patients who suffer from CFS. 
Finally, it should also be examined whether our low intensity cognitive behavioural 
intervention works through the same mechanisms as regular CBT for CFS, which has been 
shown to produce stronger effects than the low intensity intervention (Tummers et al., 2010). 
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ABSTRACT 
The aim of our study was to explore whether community-based mental health care centres 
(MHCs) are able to implement and sustain cognitive behaviour therapy (CBT) for chronic 
fatigue syndrome (CFS) with the help of an implementation manual for team leaders. We 
monitored the implementation data of three Dutch MHCs. Implementation success was 
defined as having included at least 40 CFS patients of which 30 or more completed post-
treatment assessment and as having uncontrolled effect sizes within the statistical benchmark 
range of randomised controlled trials (RCTs) in the context of CBT for CFS. All MHCs 
included 40 or more patients with CFS of which more than 30 completed post-treatment 
assessment. Two MHCs received external support in addition to the implementation manual 
to achieve these results. These MHCs both implemented CBT for CFS for the first time, one 
in the context of a stepped care program for CFS. Two of three MHCs reached effect sizes 
similar to RCTs in terms of decreasing fatigue severity and physical disability. The MHC 
with the stepped care program had less favourable outcome data in the regular CBT condition 
with effect sizes that did not meet the range of the statistical benchmark. The findings of this 
study suggest that external support in addition to a standardised implementation manual helps 
MHCs to coordinate the initial implementation of CBT for CFS. After initial implementation, 
MHCs seem able to sustain CBT for CFS without additional support. Successive 
implementation of cognitive behavioural interventions should be considered in the context of 
stepped care for CFS. 
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INTRODUCTION 
Patients with chronic fatigue syndrome (CFS) suffer from medically unexplained and severely 
disabling fatigue which lasts for at least six months (Fukuda et al., 1994). During the last two 
decades, cognitive behavioural therapy (CBT) for CFS has been developed and tested in 
specialised treatment settings (e.g. Sharp et al., 1996; Deale et al., 1997; Prins et al., 2001; 
Knoop et al., 2008; White et al., 2011). In CBT for CFS, dysfunctional illness beliefs are 
usually challenged through a gradual increase in activity and cognitive restructuring 
techniques. This strategy is effective in reducing fatigue and disabilities in CFS patients 
(Malouff et al., 2008; Price et al., 2008). Consequently, there is a growing interest in the 
dissemination of CBT for CFS outside specialised settings. For example, the Health Council 
of the Netherlands (2005) urged to implement CBT for CFS on a large national scale to treat 
an estimated number of 30.000-40.000 Dutch CFS patients. 
Scheeres et al. (2006; 2008) examined the specific requirements for successful 
implementation of CBT for CFS outside specialised treatment settings. They approached a 
community-based mental health care centre (MHC) for their purpose and found that therapists 
needed specific training and supervision in addition to the CBT for CFS manual in order to 
treat patients effectively. Also, referrers and patients had to be informed regularly about the 
additional therapy offer so that treatment capacities could be exploited adequately. In 
addition, an optimised patient flow, which included the avoidance of prolonged waiting 
periods, was necessary to reduce unexpectedly high drop-out rates. A benchmark analysis 
(Scheeres et al., 2008) showed that the MHC was similarly effective in reducing fatigue and 
disabilities under these circumstances as randomised controlled trials (RCTs) in the context of 
CBT for CFS. 
Based on this promising finding, Scheeres et al. (2006) wrote a manual in which they 
described their experiences with implementing CBT for CFS outside specialised settings. The 
main idea of this manual was that MHCs might be able to adopt CBT for CFS without 
additional help when they are adequately informed about the specific demands of the 
implementation. This could be of particular advantage for cost efficient dissemination of 
evidence-based practice for CFS on a large scale.  
The aim of the present study was to examine whether MHCs are able to implement and 
sustain CBT for CFS with the help of the implementation manual introduced by Scheeres et 
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al. (2006). For this purpose, we evaluated three different implementation scenarios: new as 
well as sustained implementation of CBT as the only intervention for CFS, and new 
implementation of CBT in the context of a stepped care program for CFS. In stepped care for 
CFS, a low intensity variant of CBT for CFS can precede regular CBT. The low intensity 
intervention consists of written self-instructions and e-mail contact with a trained therapist 
(Knoop et al., 2008). There is evidence that stepped care for CFS is equally effective but more 
time efficient than regular CBT alone (Tummers et al., 2010). 
 
METHODS 
Setting 
Our study was conducted at three Dutch MHCs. One was located in an urban region in the 
west of the Netherlands. The two other MHCs were located in rural areas, one in the east and 
one in the south of the Netherlands. All MHCs selected a team of cognitive behavioural 
therapists that was willing to participate in our study. The number of therapists who treated 
patients with CFS varied between seven at the eastern, two at the western, and four at the 
southern MHC. Each MHC also selected a team leader to coordinate the implementation of 
CBT for CFS.  
All team leaders received the implementation manual of Scheeres et al. (2006), which 
contained specific information about the use of CBT for CFS outside specialised treatment 
settings. This information included recommendations about selection, training and 
supervision of cognitive behavioural therapists, activities to inform potential referrers and 
patients about the new treatment option, and optimising patient flow from initial referral to 
end of treatment, including routine assessment of fatigue and disabilities. 
The eastern MHC sustained regular CBT for CFS from the study conducted by Scheeres 
et al. (2006; 2008). Therapists at this MHC received supervision in CBT for CFS once a 
month for one and a half hour. The western and the southern MHCs both implemented regular 
CBT for CFS for the first time. Therapists received a CBT for CFS manual, a four day 
training for therapists, and regular supervision twice a month for one and a half hour. The 
training and supervision of therapists was provided by members of our research team. 
Implementation progress was discussed with the team leaders at biannual research meetings. 
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The southern MHC also had a team of psychiatric nurses that delivered a low intensity 
intervention for CFS in the context of a stepped care program. Patients who were not 
improved after the low intensity intervention were referred to regular CBT. Patients who were 
not eligible for the low intensity intervention for some reason or who preferred face-to-face 
contact with a therapist could also start directly with regular CBT. In the present study, we 
focused on the data that were gathered during regular CBT for CFS. The effect of the low 
intensity intervention will be examined in the context of a RCT which is outside the scope of 
this study. 
 
Patients 
All patients were referred by a medical doctor with the diagnosis CFS which implied that 
patients were suffering at least six months from a severe and disabling fatigue in the absence 
of a medical explanation for the complaints (Fukuda et al., 1994; Reeves et al., 2003). We 
included patients with severe fatigue and disabilities at baseline assessment who were at least 
18 years of age.  
 
Measures 
The subscale fatigue severity from the Checklist Individual Strength (CIS) was used to 
indicate the level of fatigue (Vercoulen et al., 1994; Dittner et al., 2004). This scale consists 
of eight items which are scored on a 7-point Likert scale. The sum score varies between 8, no 
fatigue, and 56, very severe fatigue. The cut-off score for severe fatigue was 35 (or higher). 
The level of disabilities was measured with the subscales physical and social functioning from 
the 36-item Short Form Health Survey (SF–36) (Stewart et al., 1988). The scores on both 
scales range from 0, maximal limitations, to 100, maximal functioning. The cut-off score for 
severe disabilities was 65 (or less) on physical or social functioning.  
 
Data collection 
We monitored the implementation data in collaboration with the MHCs who provided 
routinely collected and anonymised patient information on a regular basis to us. This 
information included the number of patients per stage of the patient flow (i.e. referral, start of 
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treatment, end of treatment) and the assessment of fatigue and disabilities prior and 
subsequent to treatment. 
 
Analysis 
Consensus was reached prior to the start of the study that at least 40 patients should be 
included per MHC and that at least 30 of these 40 patients should complete post-treatment 
assessment. In accordance with Scheeres et al. (2008), we determined the number of clinically 
improved patients with a reliable change index of >1.96 on the CIS fatigue severity, a fatigue 
severity score of <35 and a SF-36 physical functioning score of >65. We also followed the 
statistical benchmark procedure of Scheeres et al. (2008) to test whether treatment outcome in 
our MHCs was similar to the outcome of RCTs. This procedure included an uncontrolled pre-
post benchmark effect size for fatigue severity and physical functioning which was calculated 
as (M baseline - M post-treatment) / pooled SD. MHCs that produced effect sizes within the 95% 
confidence interval of the statistical benchmark of Scheeres et al. (2008), were considered to 
be successful in generating effects similar to those found in RCTs. Our effect sizes were 
computed on the basis of intention to treat but patients who were still in treatment at the end 
of our study were excluded from the analyses. Missing data from patients who decided not to 
start with treatment or who were no longer in treatment and had not completed post-treatment 
assessment were imputed as last observation carried forward. 
 
RESULTS 
Implementation process  
As described, we defined success in terms of the implementation process as 40 or more 
inclusions per MHC of which at least 30 completed post-treatment assessment. Each of the 
three MHCs fulfilled these criteria at the end of the implementation period (table 1). 
However, during this process, our monitoring data revealed referral problems at two MHCs 
and, in particular, alarming ratios of included patients in proportion to completed post-
treatment assessments at all MHCs. Halfway through the implementation period, the eastern 
MHC had 43 inclusions and 8 completed post-treatment assessments, the western MHC had 
21 inclusions and 5 post-treatment assessments, and the southern MHC had 16 inclusions and 
1 post-treatment assessment. 
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Table 1: Implementation process data per MHC. 
 
 
 
 
Eastern 
MHC 
 
Western   
MHC 
 
Southern 
MHC  
 
included 
   mean age (SD) 
   female    
 
75 
37.2 (11.6) 
63 (84%) 
 
40 
32.3 (10.8) 
30 (75%) 
 
48 
42.6 (10.8) 
40 (83%) 
 
treated
 
   completed 
   drop-out 
   still in treatment 
67 
43 (64%) 
15 (22%) 
 9 (13%) 
39 
33 (85%) 
 5 (13%) 
1 (1%) 
47 
32 (68%) 
 5 (11%) 
10 (21%) 
Note. Percentages may not equal 100 because of rounding. 
 
We discussed this issue at one of the biannual research meetings with all team leaders and 
agreed to provide external support in addition to the implementation manual to optimise the 
use of CBT for CFS. The additional support was provided during the second half of the 
implementation period by members of our research team to the team leaders and 
administrative employees of the western and the southern MHCs where CBT for CFS was 
newly implemented. We did not intervene in the sustaining process of the eastern MHC which 
already had received additional external support by members of our research team during the 
implementation study of Scheeres et al. (2006; 2008). 
Our additional support included monthly feedback about the monitoring data for the team 
leaders of the western and the southern MHCs. This feedback contained an overview of the 
patient flow such as the number of included and treated patients, the average time patients 
waited for treatment, the average treatment time, and information about the use of post-
treatment assessment. This information was interpreted by us in terms of implementation 
success (i.e. how many more inclusions and completers are needed and what is a tolerable 
drop-out rate under the given circumstances). We provided administrative employees with 
information about missing data. In some cases, we assisted in the assessment of fatigue and 
disabilities. We also provided administrative employees with information about potentially 
stagnating treatments (i.e. treatment periods of more than 6 months). At the western MHC, we 
supported the adoption of the monitoring system by one of the therapists due to structural 
problems at the level of the administrative employees. 
 In addition, we stimulated both team leaders to intensify their patient recruitment 
activities and to optimise the patient flow for CFS patients at their MHC in accordance with 
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the implementation manual. At the western MHC, we stimulated personal presence at 
meetings of general practitioners and publications in local newspapers. At the southern MHC, 
activities were stimulated that focused on motivating patients to continue with treatment after 
ineffective low intensity interventions for CFS. Only 10 of the 23 patients (43%) who were 
eligible to continue their treatment in the context of stepped care halfway through the 
implementation period actually started with regular CBT. We also stimulated team leaders to 
reduce prolonged waiting and treatment periods to avoid drop-out of patients before and 
during treatment whenever appropriate. 
The western MHC had 19 inclusions and 28 post-treatment assessments in the period 
with external support as opposed to 21 inclusions and 5 post-treatment assessments in the 
period without external support. The southern MHC had 32 inclusions and 31 post-treatment 
assessments in the period with external support as opposed to 16 inclusions and 1 post-
treatment assessment in the period without external support. The eastern MHC also improved 
their ratio of included patients in proportion to completed post-treatment assessments after the 
meeting where it was problematised. Here, 32 patients were included and 35 post-treatment 
assessments were completed after the meeting as opposed to 43 inclusions and 8 post-
treatment assessments before the meeting. 
At the end of our study, the team leaders of the western and southern MHC reported that 
the additional external support helped them to gain more insight into the progress of their 
implementation and at the same time helped everyone to keep focused and motivated during 
the implementation process. All team leaders appreciated the fact that they were able to 
determine how much external support was ultimately provided. 
 
Treatment outcomes 
The treatment outcome data per MHC are presented in table 2. Besides the number of 
clinically significant improved patients, we calculated uncontrolled effect sizes for fatigue 
severity and physical functioning. We defined success in terms of treatment outcome as effect 
sizes that were inside the range of the confidence intervals of the statistical benchmark 
introduced by Scheeres et al. (2008).  
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Table 2: Treatment outcome data per MHC. 
 
 
 
 
Eastern 
MHC 
 
Western 
MHC 
 
Southern 
MHC 
 
intention to treat
*
 
   clinically sign. improved (%) 
   mean Δ fatigue (SD) 
   uncontrolled effect size 
   statistical benchmark
**
  
   mean Δ phys. functioning (SD) 
   uncontrolled effect size 
   statistical benchmark
**
  
 
66 
26 (39%) 
-13.9 (15.6) 
1.19 
0.97-1.89 
14.8 (21.2) 
0.65 
0.63-1.44 
 
39 
26 (67%) 
-24.0 (18.7) 
1.76 
0.97-1.89 
29.9 (26.8) 
1.23 
0.63-1.44 
 
38 
10 (26%) 
-8.6 (13.4) 
0.88 
0.97-1.89 
10.3 (22.0) 
0.43 
0.63-1.44 
 
completers
***
 
   clinically sign. improved (%) 
   mean Δ fatigue (SD) 
   mean Δ phys. functioning (SD) 
 
43 
26 (60%) 
-21.3 (14.7) 
23.0 (22.3) 
 
33 
26 (79%) 
-28.4 (16.9) 
35.3 (25.6) 
 
32 
10 (31%) 
-10.2 (14.0) 
12.2 (23.5) 
 
 
*
Patients who were still in treatment were excluded. 
**
95% confidence interval derived from  
 Scheeres et al. 2008. 
***
Patients who did not complete post-treatment assessment were excluded. 
 
The eastern and the western MHC both had effect sizes that ranged within the 95% 
confidence intervals of the benchmark, indicating that they were successful in generating 
treatment effects similar to those found in RCTs. The effect sizes for regular CBT at the 
southern MHC were significantly lower than the effect sizes of the statistical benchmark. In 
total, forty-eight patients were included for regular CBT at the southern MHC. Fifty per cent 
(n=24) of the inclusions already had received a minimal intervention for CFS in the context 
of stepped care. Two of these patients were still in treatment at the end of the study. Four 
(18%) showed clinically significant improvement. The other 50% (n=24) of the inclusions 
had not received a low intensity intervention for CFS prior to regular CBT. Eight of these 
patients were still in treatment at the end of the study. Six (38%) showed clinically significant 
improvement. 
 
DISCUSSION 
The purpose of the present study was to examine whether MHCs are able to implement and 
sustain CBT for CFS with the help of the implementation manual introduced by Scheeres et 
al. (2006). Although all three MHCs fulfilled the success criteria in terms of the 
implementation process (i.e. at least 40 inclusions and 30 completers), the two new MHCs 
74 
both received additional implementation support by our research team. This support mainly 
included assistance for the team leaders in translating the implementation manual into practice 
and their administrative employees in processing the monitoring data into meaningful 
feedback for those involved in the implementation process. 
Although our study was not primarily designed to test the effect of external support on 
implementation success, our findings suggest that we helped the MHCs to coordinate the 
initial implementation of CBT for CFS by responding to their need for more assistance. This 
would be in accordance with a notion of Fixsen et al. (2009), who stated that all professionals 
who participate in the implementation of evidence-based practice need supervision in order to 
be effective. Apparently, we have underestimated this need by limiting our supervision to the 
therapists in the first place. At the same time, we experienced the support that was based on 
the implementation manual in this study as substantially less time consuming than the support 
that was delivered in the implementation study of Scheeres et al. (2008) where no such 
manual existed. 
Although the eastern MHC also had problems with the inclusion to completers ratio 
during the implementation process, our data suggest that MHCs are capable of sustaining 
CBT for CFS successfully without external support after initial implementation. It is vital to 
notice in this context that the eastern MHC did not express a need for more external support. 
In future implementations of CBT for CFS programs, it may be most appropriate based on our 
findings to adapt the level of additional support to the specific needs of the individual MHCs. 
According to the statistical benchmark introduced by Scheeres et al. (2008), the effect 
sizes of the eastern and the western MHCs were similar to those found in RCTs. This result is 
another promising finding for future implementations of CBT for CFS outside specialised 
treatment settings. At the same time, the southern MHC had significantly lower effect sizes 
than the statistical benchmark. There are several explanations which may account for this 
finding. One possibility is that therapists at the southern MHC may have been less effective in 
treating CFS patients according to the evidence-based standard. A recent study in the context 
of manualised CBT for CFS showed that therapists inside specialised treatment settings do 
not affect treatment outcome (Cella et al., 2011). It would be interesting to examine whether 
the efficacy of therapists outside specialised settings might differ significantly and which 
characteristics might cause such a difference. 
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Another possible explanation is the fact that the southern MHC implemented more than one 
cognitive behavioural intervention at the same time in the context of a stepped care program 
for CFS. None of the cognitive behavioural therapists were specifically trained for face-to-
face contact with patients who already had received an ineffective low intensity intervention. 
This fact may have biased treatment outcome in disadvantage of the southern MHC. Although 
the number of patients was too small to test these differences statistically, our clinically 
significant improvement rates indicate that regular CBT for patients who had received the low 
intensity intervention may have been less effective than regular CBT for patients who had not 
received the low intensity intervention. Based on these findings, we would discourage 
implementation of more than one intervention for CFS at a time. We recommend to start with 
regular CBT which can be complemented with the low intensity intervention as soon as the 
initial implementation of regular CBT has been accomplished successfully. 
Our conclusions are based on the assumption that the MHCs which participated in our 
study are exemplary for the implementation situation of other MHCs. Due to the 
heterogeneity of community-based mental health care, our findings may not fit seamlessly 
into other settings in and outside the Netherlands. Although we paid attention to factors which 
may be relevant for future implementations in our selection of MHCs (e.g. rural and urban 
regions are represented as well as different implementation scenarios), future research will 
have to demonstrate how well our findings generalise to these settings. 
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ABSTRACT 
The purpose of the present study was to explore the role of the therapist in the dissemination 
of manualised cognitive behaviour therapy (CBT) for chronic fatigue syndrome (CFS) outside 
specialised treatment settings. We used the routinely collected outcome data of three 
community-based mental health care centres (MHCs) which implemented and sustained CBT 
for CFS during the course of the study. Ten therapists, who all received the same training in 
CBT for CFS, and 103 patients with CFS were included. Random effects modelling revealed 
a significant difference in mean post-treatment fatigue between therapists. The effect of the 
therapist accounted for 21% of the total variance in post-treatment fatigue in our sample. This 
effect could be explained by the therapists’ attitude towards working with evidence-based 
treatment manuals as well as by the MHC where CBT for CFS was delivered. The context in 
which CBT for CFS is delivered may play an important role in the accomplishment of 
established therapy effects outside specialised treatment settings. Due to the small sample size 
of MHCs and the different implementation scenarios in which they were engaged, our 
findings should be interpreted as preliminary results which are in need for replication. 
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INTRODUCTION 
The evolution of cognitive behaviour therapy (CBT) for chronic fatigue syndrome (CFS) in 
specialised treatment units has led to a multitude of randomised controlled trials during the 
past fifteen years (e.g. Sharpe et al., 1996; Deale et al., 1997; Prins et al., 2001; Stulemeijer et 
al., 2005; Knoop et al., 2008; White et al., 2011). These trials generally showed that CBT is 
an effective treatment for the severe and disabling fatigue that is central to the suffering of 
CFS patients (Malouff et al., 2008; Price et al., 2008).  
Several publications have recently been devoted to factors that may explain treatment 
outcome in CBT for CFS (Wiborg et al., 2010;  Knoop et al., 2010; Wiborg et al., 2011; Cella 
et al., 2011). Most of these studies focused on changes in illness-specific behaviours and 
beliefs of the patient. In the present study, we explored the role of the context in which 
patients receive manualised CBT for CFS focusing on the effect of the therapist outside 
specialised treatment settings. 
The individual therapist has received considerable attention in the endeavour to 
understand treatment outcomes in psychotherapy research (e.g. Luborsky et al., 1985; 
Lambert et al., 1989; Okiishi et al., 2003; Kim et al., 2006; Lutz et al., 2007; Cella et al., 
2011). In general, the variance in treatment outcome that can be explained by the therapist 
tends to vary substantially across studies. While some studies have found explained variance 
estimates of up to 50%, others failed to demonstrate a significant therapist effect (Crits-
Christoph et al., 1991). For example, Cella et al. (2011) recently found that 0% of the 
variance in post-treatment fatigue of a specialised CFS unit could be explained by the 
therapist. They attributed this finding to the fact that their therapists were equally well trained 
in manualised CBT for CFS. 
However, depending on the context, therapists can also differ on other relevant 
characteristics than the amount of training in a manualised therapy approach. Addis and 
Krasnow (2000) showed that the attitude towards treatment manuals varies among therapists. 
This variation may affect treatment outcome in manualised therapies. Yet, less favourable 
attitudes towards treatment manuals were found outside specialised academic treatment 
settings and may therefore only affect outcomes outside such settings. 
There is thus good reason to assume that the therapists of the specialised treatment unit 
examined by Cella et al. (2011) were generally positive about the use of treatment manuals, 
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with little variation downward. Outside specialised settings this may be fundamentally 
different, with vital consequences for the dissemination and use of manualised therapies. 
In the present study, we were interested in whether therapists of community-based mental 
health care centres (MHCs), who received the same training in manualised CBT for CFS, 
contribute to the variation in post-treatment fatigue. We were further interested in whether 
these hypothesised variations in therapist efficacy can be explained by the therapists’ attitude 
towards working with evidence-based treatment manuals as suggested by Addis et al. (1999; 
2000). 
 
METHODS 
Design 
We conducted an observational prospective study using the routine outcome data of three 
Dutch MHCs. All MHCs participated in a study about the implementation of CBT for CFS. 
One MHC sustained CBT for CFS from a pilot implementation (Scheeres et al., 2008). The 
two other MHCs implemented CBT for CFS during the course of this study. In one of these 
MHCs, the efficacy of a minimal intervention for CFS was tested simultaneously. As a result, 
some patients were referred to CBT after the minimal intervention. Data were gathered 
between 2008 and 2011 and included fatigue severity scores prior and subsequent to CBT for 
CFS and the therapists’ attitude towards treatment manuals before patients were treated in the 
context of this study. 
All therapists were trained and supervised in CBT for CFS by members of our research 
team. We analysed the data of therapists who treated at least three CFS patients including 
post-treatment assessment. Patients were referred by a medical doctor with the diagnosis CFS 
which implied that patients were suffering at least six months from a severe and disabling 
fatigue in the absence of a medical explanation for the complaints (Fukuda et al., 1994; 
Reeves et al., 2003). Patients who had fatigue scores below the cut-off level for severe fatigue 
at pre-treatment assessment as described beneath or who did not complete post-treatment 
assessment were excluded from this study. In total, 10 therapists and 103 patients were 
included. CBT for CFS was based on the treatment manual described by Bleijenberg et al. 
(2003) and Knoop and Bleijenberg (2010) and included goal setting, fixed sleep wake cycles, 
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changing the focus on bodily symptoms, a systematic challenge of fatigue-related beliefs, 
regulation and gradual increase of activity, and the accomplishment of personalised goals. 
 
Instruments 
The subscale fatigue severity from the Checklist Individual Strength (CIS) was used to 
indicate the level of fatigue experienced by patients (Vercoulen et al., 1994; Dittner et al., 
2004). The scale consists of eight items which are scored on a 7-point Likert scale. The sum 
score varies between 8, no fatigue, and 56, very severe fatigue. The cut-off score for severe 
fatigue was 35. The internal consistency of the fatigue severity scale has been found to be 
good (α = .88) (Vercoulen et al., 1994). 
Therapists’ attitude towards working with evidence-based treatment manuals was 
assessed with the survey questionnaire introduced by Addis et al. (2000) which was translated 
into Dutch for this purpose. The questionnaire consists of 17 items which load on two factors. 
The factor negative process reflects the idea that treatment manuals pose a threat to the 
freedom and flexibility of the therapist. The factor positive outcome addresses the idea that 
treatment manuals can enhance therapeutic results. The internal consistency of these factors 
has been found to be α = .93 for negative process and α = .80 for positive outcome (Addis et 
al., 2000).  
 
Data analysis 
We computed a series of multi-level random effects models using the lme4 library in R 
(Bates, 2010). The statistical significance of our effects was tested with 95% profile deviance 
confidence intervals (CI) using maximum likelihood fits. A confidence interval that did not 
include zero indicated statistical significance. Undefined lower bounds were interpreted as 
zero. At first, we computed a baseline model with post-treatment fatigue scores as dependent 
variable and therapist effect as random factor. An intra-class correlation coefficient (ICC) was 
computed as ratio of the therapist variance to the total variance. Next, we added both 
subscales of the therapists’ attitude towards treatment manuals as fixed factor to the baseline 
model. Since therapists were delivering treatment at different MHCs, we also computed a 
model in which the treatment setting was added as fixed factor to the baseline model. We 
computed dichotomous dummy variables for this purpose. MHC I was used as reference 
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category in the dummy coding process (this MHC sustained CBT for CFS from an earlier 
implementation). All models were controlled for pre-treatment fatigue. 
 
RESULTS 
An overview of the distribution of patients and therapists among MHCs is presented in table 
1, including therapist attitude and mean fatigue scores per therapist at pre-treatment and post-
treatment assessment.  
 
Table 1: The distribution of patients and therapists among community-based mental health care centres (MHCs), 
including therapist attitude and mean fatigue scores per therapist at pre-treatment and post-treatment assessment. 
 
 
therapist  
and setting 
 
number of  
patients 
 
mean pre-treatment 
 fatigue (SD) 
 
mean post-treatment  
fatigue (SD) 
 
therapist attitude  
 
neg. process 
 
pos. outcome 
 
MHC I 
1 
2 
3 
4 
5 
40 
8 
4 
9 
11 
8 
50.6 (4.4) 
49.4 (3.6) 
51.8 (2.2) 
49.0 (5.2) 
52.5 (3.0) 
50.6 (6.0) 
30.0 (14.7) 
37.5 (14.2) 
31.5 (15.0) 
20.0 (11.9) 
31.6 (16.7) 
30.6 (12.3) 
21.9 (1.2) 
23 
21 
20 
22 
23 
32.0 (6.8) 
26 
40 
24 
40 
32 
 
MHC II 
1 
2 
3 
30 
11 
4 
15 
50.3 (6.1) 
52.2 (6.1) 
47.0 (8.8) 
49.7 (5.2) 
39.3 (12.7) 
46.1  (7.6) 
41.8 (10.7) 
33.7 (13.9) 
27.5 (0.5) 
27 
27 
28 
42.6 (5.0) 
40 
33 
47 
 
MHC III 
1 
2 
33 
16 
17 
51.0 (5.6) 
53.0 (3.5) 
49.2 (6.6) 
22.7 (16.1) 
 22.8  (16.1) 
 22.5  (16.5) 
22.5 (0.5) 
22 
23 
38.5 (0.5) 
39 
38 
 
total 103 50.7 (5.2) 30.4 (15.9) 23.7 (2.6) 37.2 (6.7) 
 
Our baseline model revealed that there was a significant effect of the therapist on treatment 
outcome (variance component estimate = 53.0; CI: 10.3, 164.7). The ICC equalled .21 which 
indicated that 21% of the variance in post-treatment fatigue could be explained by the 
individual therapist (correcting for pre-treatment fatigue). Next, we added both attitude 
subscales to the baseline model. The variance component estimate for the therapist effect 
decreased from 53.0 to 21.8 (CI: 0.0, 63.3). The variance component estimates for negative 
process and positive outcome were 2.7 (CI: 0.9, 4.5) and -0.4 (CI: -1.0, 0.3) respectively, 
indicating that negative process was a significant predictor of the model. 
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In the final model, in which the treatment setting was added to the baseline model, the 
variance component estimate for the therapist effect dropped from 53.0 to 16.4 (CI: 0.0, 49.5). 
The variance component estimates for MHCs II and III were 9.7 (CI: 1.6, 18.0) and -7.4 (CI:  
-15.9, 1.1) respectively, indicating that MHC II (i.e. the MHC were the minimal intervention 
was implemented simultaneously) was the least effective in reducing fatigue in the regular 
CBT condition. In both models, the 95% confidence interval included zero which indicates 
that the therapist effect was no longer significant when either attitude or treatment setting 
were added to the baseline model. However, the confidence intervals of all models were large 
and overlapped each other. 
 
DISCUSSION 
In the present study, we explored the role of the context on treatment outcome in manualised 
CBT for CFS outside specialised treatment settings. We found that equally well trained 
therapists produce different outcomes. The effect of the therapist accounted for 21% of the 
total variance in post-treatment fatigue in our sample. This finding differs from the results of a 
recent publication by Cella et al. (2011) in which no therapist effect on treatment outcome 
was found following CBT in a specialised CFS unit. Our finding is in line, however, with the 
explained variance estimates reported in a meta-analysis by Crits-Christoph et al. (1991) 
which ranged between 0% and 50%. 
In additional, we found that there was a substantial decrease in therapist effect when both 
attitude subscales were added to the model. In particular, a stronger belief that treatment 
manuals threaten the freedom and flexibility of therapists seems to be related to less effective 
treatments. To our knowledge, this study is the first one to link the attitude of therapists 
towards evidence-based treatment manuals to the efficacy of manualised therapy approaches. 
Our analyses also revealed that the setting where therapists delivered CBT for CFS might 
as well account for the differences in therapist efficacy. An inspection of table 1 reveals that 
the scores on negative process and post-treatment fatigue are in fact mainly consistent with 
the setting where CBT for CFS was delivered. This finding may indicate an interplay between 
therapists and the setting in which they are employed. Treatment settings may, for example, 
facilitate certain beliefs about the use of treatment manuals in therapists or attract therapists 
who feel comfortable with the prevailing attitude of a given setting. Some settings may 
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therefore be less suitable for the dissemination of manualised therapies than others which 
might be reflected by the attitude of their therapists towards treatment manuals. However, 
negative beliefs about manualised therapies may also be receptive to change which could be 
induced through specific interventions that are delivered by external experts (Addis et al., 
1999). 
A major limitation of our study is that all MHCs were engaged in different 
implementation scenarios during the course of our study which may have affected treatment 
outcome. While two MHCs implemented CBT for CFS, one sustained it from an earlier 
implementation study. More experience in CBT for CFS might, for example, produce more 
favourable treatment outcomes. However, the MHC with the most favourable results was not 
the one that sustained CBT for CFS. In addition, the therapists of one MHC were confronted 
with patients who had already received an ineffective minimal intervention for CFS. This 
MHC had the least favourable outcomes. There was a trend at this MHC which suggests that 
treatment for patients who did not receive the minimal intervention might have been more 
effective than regular CBT following the low intensity intervention. Since we conducted an 
explorative study with the routinely collected outcome data of an implementation study, we 
were also not able to allocate patients randomly to the therapists which may have biased 
treatment outcome as well. Although we corrected for fatigue severity at baseline assessment, 
comorbidity may have complicated the caseload of some therapists more than that of others 
for example. 
Representative data from routine clinical practice of CBT for CFS are scarce (Scheeres et 
al., 2008). This is particularly true for data being collected outside the context of specialised 
treatment settings. Understanding which factors may facilitate or impede established 
treatment effects in these settings is a major challenge for the dissemination of evidence-
based interventions. Our study contributed to this endeavour with preliminary findings 
suggesting that the context where CBT for CFS is delivered may play an important role. 
Replication of our findings with a greater sample of MHCs is needed to show that these 
findings are not exclusively a consequence of the implementation scenario. 
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ABSTRACT 
Many patients with chronic fatigue syndrome (CFS) seem to experience periods in which they 
are bound to home due to their symptomatology. Despite the ever growing body of 
knowledge about CFS, little is known about patients who feel no longer able to leave their 
house. The purpose of the present study was to examine whether homebound patients differ 
from other CFS patients on illness specific characteristics. Besides experiencing more 
impairment in daily functioning than participants of an outpatient intervention study, 
homebound patients were characterised by extremely high levels of daily fatigue, 
predominant somatic attributions and pervasively passive activity patterns. The course of 
symptomatology was similarly stable in both groups. Our findings suggest that homebound 
patients form a distinct subgroup of CFS patients who might profit from a treatment approach 
which is tailored to their specific needs. The exploratory nature of this first systematic 
investigation of homebound CFS patients is stressed and suggestions for future research are 
made. 
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INTRODUCTION 
Chronic fatigue syndrome (CFS) is characterised by severe and disabling fatigue which 
persists at least six months and which is not the result of a medical condition (Fukuda et al., 
1994). CFS can dominate the life of patients to such a degree that they feel no longer able to 
leave their house any more. According to surveys held by patient organisations, many patients 
with CFS seem to have experienced a period in which they were bound to their homes due to 
their symptomatology (e.g. Action for M.E., 2001). Unfortunately, virtually all scientific 
effort has been concentrated on CFS patients who were able to visit outpatient treatment 
settings. Thus, little is known about the illness specific characteristics of homebound CFS 
patients. More insight into these characteristics will enhance the understanding of the 
complex nature of CFS and may also contribute to the development of  specifically tailored 
treatment approaches. 
The purpose of the present study was to determine whether homebound patients differ 
from other CFS patients on illness specific characteristics. For this purpose, we compared a 
group of homebound patients with the natural course condition of an outpatient intervention 
study, previously conducted to test the effect of cognitive behaviour therapy (CBT) for CFS 
(Prins et al., 2001). The two groups were compared on multiple illness specific dimensions, 
validated for the clinical evaluation of patients with medically unexplained fatigue (Vercoulen 
et al., 1994). Besides the assessment of fatigue, impairment and additional complaints such as 
concentration problems, unrefreshing sleep and the deterioration in psychological wellbeing, 
those factors were assessed which have been shown to inflate and prolong symptomatology in 
CFS (Vercoulen et al., 1994; 1998). These perpetuating factors have received much attention, 
both in research and cognitive behaviour therapy for CFS (Prins et al., 2006). Prominent 
factors are physical inactivity, caused by the idea that the complaints are due to a somatic 
cause, and an experienced lack of control over symptoms. We hypothesised that the scores on 
these factors are more problematic in homebound patients than in outpatients, leading to more 
severe fatigue and impairment. 
Earlier research has shown that spontaneous recovery in CFS is rare (for a systematic 
review see Cairns & Hotopf, 2005). No specific findings exist about the course of CFS in 
homebound patients. We therefore reassessed the severity of fatigue and impairment at one 
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year follow-up and tested whether the course of symptomatology in homebound patients 
differs from that of outpatients. 
 
METHODS 
Design 
A Dutch patient organisation was asked to recruit CFS patients among its members who felt 
bound to their home. In order to participate, these members had to be between 18 and 60 
years of age, had to meet the CDC criteria for CFS (Fukuda, 1994) and should not have 
participated in research on CFS before. Eighteen members fulfilled these criteria and were 
visited twice at home during a period of two weeks to complete baseline assessment. To 
prevent attrition among homebound patients, a limited test battery was used at follow-up 
assessment 12 months later. Fifteen homebound patients were able to complete follow-up 
assessment.  
As reference group, we chose the natural course condition of a multi-centre randomised 
controlled trial, previously conducted by Prins et al. (2001) to test the effect of CBT on CFS. 
These 88 patients differed from the group of homebound patients in that they were able to 
participate in an outpatient treatment study despite of their symptomatology. In this trial, 
follow-up assessment took place 14 months after baseline assessment. Seventy-nine of the 88 
patients completed follow-up assessment. 
  
Assessment 
Checklist Individual Strength: We used subscales of the Checklist Individual Strength (CIS) 
to assess fatigue severity and concentration problems. Higher scores indicate more severe 
fatigue and problems with concentration. The CIS is a reliable and valid instrument for 
multidimensional assessment of fatigue in CFS (Vercoulen et al., 1994; Dittner et al., 2004). 
 
Daily observed fatigue: Patients were asked to rate the intensity of fatigue four times a day 
from 0 (no fatigue) to 4 (intense fatigue). The daily sum score was averaged across a period of 
two weeks (Vercoulen et al., 1996a). This score was used to compare fatigue levels at 
baseline because daily assessment of fatigue is less prone to a ceiling effect than single 
assessment of fatigue. 
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Sickness Impact Profile: Several subscales of the Sickness Impact Profile (SIP; Bergner et al., 
1981) were used to measure impairment in different areas of functioning due to health 
problems. We were interested in the subscales home management, ambulation, mobility, 
alertness behaviour, social interactions, and sleep. Higher weighted scores indicate more 
impairment on these scales. 
 
Karnofsky scale: The Karnofsky performance status scale (O'Dell et al., 1995) is a 
descriptive, ordinal scale. An independent clinical psychologist rates patient’s level of daily 
functioning at 10-point intervals from 0 to 100. Lower ratings indicate more impairment in 
daily functioning. 
 
Symptom Checklist: The Dutch version of the Symptom Checklist 90 (SCL; Arindell & 
Ettema, 1986) was used to assess psychological wellbeing. We were interested in the 
subscales anxiety, agoraphobia, depression, interpersonal sensitivity, somatisation, and sleep. 
Higher scores indicate more problems in these areas. 
 
Actometer: Actigraphy was used to assess the level of physical activity. The Actometer is a 
motion-sensing device which is worn around the ankle during a period of two consecutive 
weeks. A mean score was computed to indicate the average daily level of physical activity, 
with higher scores indicating more physical activity. The Actometer has been shown to be a 
reliable and valid instrument for the assessment of physical activity in CFS (van der Werf et 
al., 2000). 
  
Causal Attribution List: Attribution of CFS related symptoms was assessed with the Causal 
Attribution List (CAL). Somatic as well as non-somatic attributions were assessed on a 4-
point Likert scale with 5 items per subscale. The mean norm score for CFS patients on 
somatic attributions is 14.0 (SD = 2.6) and 9.1 (SD = 2.4) on non-somatic attributions (de 
Vree et al., 2002), with higher scores indicating a stronger tendency to attribute symptoms to 
a certain cause. The internal consistency of the CAL ranges between .71 and .77 (Vercoulen 
et al., 1996b; Prins et al., 2001; de Vree et al., 2002). 
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Self-efficacy scale: Sense of control over fatigue was measured with the Self-Efficacy Scale 
(SES). This scale consists of five items. Four of these items were scored on a 5-point and one 
item on a 4-point Likert scale. Higher scores on the SES reflect more sense of control over 
symptoms. The mean norm score for CFS patients is 15.6 (SD = 3.4) and the internal 
consistency ranges between .68 and .77 (Prins et al., 2001; de Vree et al., 2002). 
 
Statistical analysis 
To avoid bias due to considerable differences in group size (i.e. 18 vs. 88), we selected the 28 
patients of the natural course condition who scored within the same range as the homebound 
patients on age, gender and illness duration (i.e. between 27 and 56 years of age, female, with 
an illness duration between 4 and 32 years). Twenty-five of these 28 patients completed 
follow-up assessment. 
Not all variables were normally distributed. Therefore, Mann-Whitney’s non-parametric 
test was used to analyse differences between the groups. At first, we tested the differences in 
age and illness duration to assure that differences on the main outcome measures were not 
simply due to differences on these variables. Then, we tested the median differences on the 
main outcome measures at baseline assessment. Finally, we examined the median differences 
in change scores (follow-up versus baseline) on fatigue and impairment. The p-value for 
statistical significance has been set at p < .05. Due to the exploratory nature of the study, no 
formal correction for a type I error has been applied. 
 
RESULTS 
In table 1, the baseline differences between homebound patients and outpatients are shown. 
While the group of homebound patients did not differ significantly from the selection of 
outpatients in age, illness duration, and education, none of the homebound patients held a paid 
occupation, which was significantly less employment than was found in the selection of 
outpatients. The group of homebound patients also differed from the selection of outpatients 
on the three dimensions fatigue, daily functioning, and physical activity. All scale differences 
on these dimensions were significant to the detriment of the homebound patients.   
 Table 1: Testing differences in median baseline scores (range) between homebound patients         
and the selection of outpatients using Mann-Whitney’s test 
 
 
homebound 
(n = 18)  
selection 
outpatients 
 (n = 28) 
 
z 
 
P 
patient characteristics 
   age in years 
   female 
   illness duration in years 
   paid occupation 
   education
b 
 
41.5 (27-56) 
18 (100%) 
10.0 (4-32) 
0 (0%) 
4 (2-7) 
 
45 (27-56) 
28 (100%) 
7.5 (5-25) 
8 (28%) 
4.5 (1-7) 
 
-0.79 
n.a. 
-0.39 
n.a. 
-0.20 
 
.430 
n.a. 
.700 
.015
a 
.845 
psychological wellbeing 
   SCL anxiety 
   SCL agoraphobia 
   SCL depression 
   SCL sensitivity 
   SCL somatisation 
 
15 (3-30) 
7 (7-21) 
26.5 (20-51) 
20 (18-41) 
33 (23-52) 
 
14 (9-30) 
8 (7-18) 
28 (16-59) 
24 (19-43) 
29 (14-45) 
 
-0.20 
-1.22 
-0.78 
-2.04 
-2.03 
 
.839 
.222 
.436 
.041 
.042 
fatigue 
   daily observed fatigue 
 
14.1 (8.6-15.6)
c 
 
7.3 (0.4-13.2)
d 
 
-4.77 
 
.000 
daily functioning 
   SIP home management 
   SIP ambulation 
   SIP mobility 
   Karnofsky scale 
 
309 (54-498) 
231.5 (0-678) 
336.5 (86-457) 
50 (40-70)
c 
 
216 (54-421) 
137 (0-315) 
127.5 (0-585) 
70 (60-90)
c 
 
-2.29 
-2.85 
-4.35 
-5.28 
 
.022 
.004 
.000 
.000 
concentration 
   SIP alertness behaviour 
   CIS concentration 
 
309.5 (0-687) 
24 (5-35) 
 
403.5 (0-777) 
29 (5-35) 
 
-1.35 
-2.01 
 
.176 
.044 
social functioning 
   SIP social interactions 
 
235.5 (44-683) 
 
325.5 (123-696) 
 
-0.98 
 
.327 
sleep 
   SCL sleep 
   SIP sleep 
   hours sleep at night 
   hours sleep at daytime 
 
7.5 (3-15) 
144 (83-499) 
7 (3-13) 
1 (0-6) 
 
7 (3-13) 
173.5 (49-395) 
8.5 (5-12) 
1 (0-4) 
 
-0.82 
-0.66 
-1.16 
-0.35 
 
.414 
.512 
.248 
.972 
physical activity 
   actigraphy 
 
28.5 (5-46) 
 
60 (30-97) 
 
-5.11 
 
.000 
causal attributions 
   CAL somatic 
   CAL non-somatic 
 
16.5 (9-20) 
10.5 (4-14) 
 
14.5 (10-18) 
9 (5-14) 
 
-2.62 
-0.35 
 
.009 
.725 
sense of control 
   SES 
 
14 (6-21) 
 
13.5 (10-20) 
 
-0.21 
 
.837 
Note. 
a Fisher’s exact test. bHigher scores indicate a higher level of education.  
c
One patient missing. 
d
Three patients missing. 
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No significant differences were found on the dimensions social functioning, sleep and sense 
of control. The results for the dimensions psychological wellbeing, concentration, and causal 
attributions were mixed. While the two groups did not differ on most scales of the dimension 
psychological wellbeing, the median scores on interpersonal sensitivity and somatisation were 
significantly different between the two groups. According to the CIS concentration, the two 
groups also differed significantly on the dimension concentration but this finding was not 
supported by the SIP alertness behaviour. Finally, homebound patients attributed their 
symptoms significantly more to a somatic cause than the selection of outpatients. A 
significant difference on non-somatic attributions was not found.  
The differences in change scores between the group of homebound patients and the 
selection of outpatients are presented in table 2. All reassessed scales indicate that the change 
from baseline to follow-up was not significantly different between the two groups. 
 
 Table 2: Testing differences in median change scores (range) between homebound patients and the selection of 
outpatients using Mann-Whitney’s test 
 
 
homebound 
(n = 15)  
selection 
outpatients 
 (n = 25) 
 
z 
 
P 
fatigue 
   Δ CIS fatigue severity 
 
0 (-21–12) 
 
-2 (-37–7) 
 
-0.53 
 
.593 
daily functioning 
   Δ SIP home management 
   Δ SIP ambulation 
   Δ SIP mobility 
 
0 (-208–177) 
-27 (-284–490) 
-48 (-223–376) 
 
0 (-202–154) 
-1 (-213–140) 
0 (-438–170) 
 
-0.56 
-0.25 
-0.59 
 
.576 
.801 
.556 
concentration 
   Δ SIP alertness behaviour 
   Δ CIS concentration 
 
0 (-180–219) 
-2 (-9–9) 
 
-55 (-299–153) 
0 (-14–15) 
 
-1.58 
-0.04 
 
.114 
.966 
social functioning 
   Δ SIP social interactions 
 
0 (-363–264) 
 
-49 (-366–221) 
 
-1.31 
 
.189 
sleep 
   Δ SIP sleep 
 
0 (-248–107) 
 
-60 (-346–70) 
 
-1.08 
 
.280 
 
DISCUSSION 
Our findings suggest that homebound patients differ from other patients with CFS in a 
number of ways. At first, homebound patients were less likely to hold a paid occupation and 
experienced more impairment in daily functioning. This finding conceptually supports the 
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notion of being bound to home. Second, homebound patients experienced considerably higher 
levels of daily fatigue and were considerably less physically active. In fact, two thirds of their 
daily fatigue scores and half of their Actometer scores were not at all present in the reference 
group and all homebound patients were characterised by a pervasively passive activity pattern 
with an extremely low level of physical activity on almost all days (van der Werf et al., 2000). 
Furthermore, homebound patients were more prone to attribute their symptoms to a somatic 
cause than outpatients. Although homebound patients experienced considerably more fatigue 
and impairment, they did not report more change in symptomatology during the follow-up 
period than outpatients. In fact, many median change scores were equal to zero. 
On the other hand, homebound patients did not feel socially more impaired or 
experienced less sense of control over their symptoms than outpatients. They were also not 
psychologically more distressed. At first sight, these latter findings may seem contradictory. 
One would assume that patients who are bound to home due to their symptomatology should 
also experience more distress and less sense of control over their symptoms. However, an 
extremely high level of daily fatigue in combination with a predominant belief in a somatic 
cause (while no somatic cure is available), might have urged these patients to withdraw from 
virtually any activity to exercise at least some control over their fatigue. While this way of 
adapting to the condition might have resulted in an increase in sense of control and a decrease 
in psychological distress, it could have also bound these patients to their homes and made 
them dependent on the help of others. 
Besides resulting in serious impairment, this hypothesised way of adapting to the 
condition may also seriously complicate the delivery of treatment as any belief in the 
possibility to change might have been diminished in these patients. In addition, the 
predominant somatic attributions may cause a general reluctance towards psychological 
interventions. As a consequence, simply offering a home variant of treatment might be 
insufficient to reach these patients. In fact, although all of the participating homebound 
patients remained homebound at follow-up assessment none accepted our offer to follow CBT 
for CFS at home. When tailoring specific interventions for homebound patients, it should 
therefore be considered to facilitate a belief in the possibility to change in these patients as 
well as to increase the acceptability of psychological interventions to accomplish change. 
Furthermore, the social environment of homebound patients should actively be involved in 
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the treatment because others may unwittingly contribute to the persistence of the condition by 
taking over too many activities of the patient. 
The number of homebound patients with CFS available for participation in our study was 
smaller than expected. As a consequence, the sample size of homebound patients remained 
restricted. Although we were able to detect a meaningful pattern of substantial differences 
which should allow for the discrimination of homebound CFS patients, the nature of this first 
systematic investigation of homebound CFS patients should be understood as being primarily 
exploratory. Our findings should therefore be cross-validated by future research. Furthermore, 
our adaptation hypothesis can be tested by following patients “at risk” of becoming bound to 
home. According to our findings, such patients are characterised by extremely high levels of 
daily fatigue, predominant somatic attributions and pervasively passive activity patterns. 
Finally, our suggestions for a treatment approach which is specifically tailored to the situation 
of homebound CFS patients can be further elaborated and tested in prospective treatment 
studies. 
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n the preceding six chapters, new insights were gained about the mechanisms of successful 
change and the implementation of cognitive behaviour therapy (CBT) for chronic fatigue 
syndrome (CFS). In this final chapter, the scientific and clinical implications of these new 
insights are discussed in more detail. 
 
UNDERSTANDING EVIDENCE-BASED PRACTICE FOR CFS    
A recent meta-analysis (Bronwyn et al., 2011) showed that CBT and graded exercise therapy 
(GET) are both moderately effective interventions for the treatment of CFS. This meta-
analysis  replicated earlier findings of systematic reviews about the treatment of CFS 
(Edmonds et al., 2004; Chambers et al. 2006 , Price et al., 2008; Malouff et al., 2008). In 
contrast to the extensive research literature on whether CBT and GET work, few empirical 
studies have raised the question how these interventions generate their effects. Different 
models have been proposed to explain how CBT and GET for CFS may work but none of 
them has been tested empirically. As a consequence, we do not know why patients profit from 
evidence-based practice for CFS or how we may increase the moderate efficacy of these 
interventions. A straightforward way to search for an answer to these questions is to test 
which variables mediate the effect of treatment (Baron & Kenny, 1986; Frazier et al., 2004). 
A significant mediation effect indicates  that a treatment works through a change in the 
intervening variable. In addition, moderators and predictors of the treatment effect can be 
examined to determine which variables may impede or facilitate the proposed mechanisms of 
change (Frazier et al., 2004). 
 
Mechanisms of change  
Moss-Morris et al. (2005) conducted the first mediation analysis in the context of GET for 
CFS. This study acted as a model for our analyses of three previously conducted randomised 
controlled trials (RCTs) of CBT for CFS (chapters 2-4). All analyses showed that a reduction 
in fatigue could not be explained by a change in physical parameters or physical activity, 
neither in GET (Moss-Morris et al., 2005) nor in CBT for CFS (Wiborg et al., 2010a). We 
found no change in the level of physical activity due to our interventions. Nevertheless, all 
interventions were effective in reducing fatigue and impairment. In sum, these findings do not 
I 
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support the idea that patients need to reverse physical deconditioning in order to improve 
(Fulcher & White, 1997). 
 Instead, all mediation analyses revealed that a persistent change in cognitive processes 
mediated the effect of treatment. A decrease in focusing on fatigue mediated the effect of 
GET for CFS (Moss-Morris et al., 2005) and CBT for CFS (Wiborg et al., 2011). A decrease 
in perceived problems with activity and an increase in perceived control over fatigue were 
also significant mediators of the effect of CBT for CFS. These two mediators were validated 
in the same treatment model showing that they added independently of one another to the 
effect of treatment (Wiborg et al., 2012). A decrease in focusing on symptoms did not yield 
significance in these latter analyses which may have been due to the instrument that was used 
to assess focusing on symptoms in the corresponding trial.  
 
Change in physical activity 
Mediation analysis helped to elucidate that there is no empirical support for a vital role of 
changes in physical activity in evidence-based practice for CFS even though this was one of 
the central ideas of these interventions. It also helped to identify more promising mechanisms 
based on current insights about the perpetuation of CFS (Knoop et al., 2010a). The validity of 
these findings might be limited, however, by the fact that in none of the studies mediators 
were assessed during treatment. A temporary change in physical activity may thus have 
occurred during treatment which could have facilitated a persistent change in cognitions that 
might not have been realised otherwise. In that case, temporary changes in physical activity 
could still be necessary to treat CFS effectively, even though a persistent change in physical 
activity is not vital to improvement. 
 The role of physical activity may, however, also vary depending on the activity pattern of 
patients (van der Werf et al., 2000). Due to the dominance of relatively active patients in our 
samples, we were not able to test our mediation hypothesis as being moderated by activity 
pattern. That is, an increase in physical activity may mediate the effect of treatment on the 
symptomatology of pervasively passive patients but not of relatively active patients. If this 
was the case, a reversion of physical deconditioning might be a crucial mechanism of change 
in some but not all patients due to the heterogeneity of the patient population. Analogous to 
our findings, Bazelmans et al. (2001) found that physical deconditioning is no perpetuating 
103 
factor in CFS but suggested to replicate their findings in pervasively passive patients to 
further validate this conclusion. Changes in physical activity could thus play a role in the 
treatment of CFS but based on the present findings this role should be limited to temporary 
influences or subgroups of patients. For the majority of CFS patients, a change in cognitive 
processes seems to be vital to improvement. 
 
Change in perception 
Based on our findings, one important aspect of these cognitive processes concerns a change in 
perceptual biases with respect to activity. It has been reported before that CFS patients tend to 
underrate their ability to engage in activity independent of their objective performance 
(Knoop et al., 2010a). They also tend to stop earlier with physical activities due to a greater 
perceived effort than matched controls (Fulcher & White, 2000; Bazelmans et al., 2001). We 
found that a change in perceptual biases mediated the effect of CBT for CFS. In particular, 
those patients improved who reported a decrease in perceived problems with activity together 
with an increase in perceived control over fatigue. 
Closely related to these mediators is the concept of self-efficacy. With respect to activity 
in CFS patients, self-efficacy could be defined as the perceived ability to engage in activity 
despite symptoms. Although we did not directly assess this concept in our studies, our 
findings may suggest that a successfully accomplished activity program which is not 
attributed to an increased ability to engage in activity could be one of the reasons why patients 
do not improve. Therapists may therefore stimulate this attribution by explicitly asking 
patients whether they are experiencing an increase in their ability to engage in activity during 
the activity programs. If patients are still reporting a lack of self-efficacy at the end of these 
programs, therapists might directly intervene by asking what is missing in terms of activity in 
order to convince the patient that his or her ability to engage in activity has increased since 
the beginning of the therapy (Knoop & Bleijenberg, 2010b). 
 In addition, therapists may also consider to discuss with their patients that there is 
increasing evidence that perceptual biases are a central feature of CFS. They could explain 
that this means that it is hard for patients to estimate their ability to engage in activity 
properly. As a consequence, patients tend to invalidate themselves unintentionally. A purpose 
of the treatment is to learn through activity programs that one is able to engage in meaningful 
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patterns of activity independent of the symptoms. Bringing these processes to the attention of 
the patient may help to avoid that changes in activity patterns are misattributed. Also, 
therapists may be withheld from misinterpreting the role of changes in physical activity as 
aim in itself and are stimulated to focus on perceptual changes instead. 
 
Change in emotion 
Besides cognitive and behavioural processes, emotions may also play a role in CBT for CFS. 
Godfrey et al. (2007) conducted a study about CBT versus non-directive counselling in 
primary care patients with fatigue. They gathered ratings on various therapy features based on 
audio tapes and linked these ratings to treatment outcome. Higher scores on 
acknowledgement and acceptance of emotional distress during both treatments were 
associated with less fatigue at six months follow-up. In addition, Brooks et al. (2011) 
examined change patterns in CBT for CFS and found that more acceptance of fatigue 
following treatment was associated with less fatigue and better physical functioning. Learning 
to accept emotional distress and fatigue may thus be an additional mediator of the positive 
effect of treatment in CFS patients. 
 It has been proposed that a decrease in fear of activity and related avoidance behaviours 
may also play a role in the treatment of CFS (Deale et al., 1997; White et al., 2011). Even 
though we found no evidence for the idea that a decrease in avoidance of activity or aversive 
stimuli may mediate the effect of CBT for CFS, Deale et al. (1998) found a link between 
changes in avoidance related beliefs and treatment outcome in CFS patients. In particular, the 
fear avoidance model may account for the group of pervasively passive patients who 
disengage from activity without the characteristic bursts of activity which are typically found 
in relatively active patients. Catastrophising beliefs about the potential harm of activity may 
feed fear and avoidance of activity in pervasively passive patients. Exposure to activity may 
help to challenge these beliefs and thereby facilitate a decrease in fear and avoidance of 
activity which may contribute to the effect of treatment in these patients. 
 
Determinants of the treatment response 
Most studies about the response of patients to evidence-based interventions for CFS have 
focused on the identification of baseline patient characteristics to predict treatment outcome 
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(Rimes & Chalder, 2005; Prins et al., 2006). A baseline patient characteristic that has been 
shown to impede treatment outcome may lead to changes in the treatment routine to enhance 
the efficacy of the intervention. For example, when our research group had found that 
pervasively passive activity patterns at baseline assessment predicted unfavourable treatment 
outcomes in CBT for CFS (Prins et al., 2001), we modified our treatment manual which 
resulted in better outcomes for these patients (Stulemeijer et al., 2005).  
 Bronwyn et al. (2011) identified the first determinant of the treatment response that 
exceeded the level of the patient. They found that primary care settings generate significantly 
smaller effects than secondary care settings, making it disputable whether CBT for CFS 
should be delivered in primary care. This finding is particularly interesting because it suggests 
that the range of factors that may impede or facilitate mechanisms of change in the treatment 
of CFS is not limited to characteristics of the patient. A number of additional variables can be 
imagined at the level of the therapist and the setting where treatment is delivered which could 
help to better understand the accomplishment of treatment effects in evidence-based practice 
for CFS. Taking the interdependence of factors from different levels into consideration may 
also help to better reflect the complexity of the treatment reality. Such an enhanced 
understanding could lead to further modifications in the delivery of treatment which may help 
to enhance the effects of these interventions as well. 
 In chapter 6, we examined data from three Dutch community-based mental health care 
centres (MHCs) which implemented or sustained CBT for CFS. Keeping in mind that 
determinants of the treatment response may exceed the level of the patient, we were 
particularly interested in the influence of the therapist on treatment outcome. Cella et al. 
(2011) recently found no therapist effect in a specialised treatment unit for CFS and argued 
that this finding might be explained by the fact that therapists received the same training in 
manualised CBT for CFS. If this assumption would hold true outside the context of 
specialised (academic) treatment settings, a vital source of potential noise for successful 
disseminations of manualised CBT for CFS might be easily controlled for by training. 
 Yet, Addis & Krasnow (2000) showed that therapists of specialised treatment units are 
generally positive about manualised therapy which was not necessarily the case outside such 
settings. Based on these findings, we hypothesised that therapists who work in MHCs may 
affect treatment outcome and that less favourable beliefs about treatment manuals may predict 
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less effective therapies. Our analyses confirmed these hypotheses. A substantial part of the 
treatment effect could be explained by the therapist. The belief of therapists that treatment 
manuals threaten their freedom and flexibility predicted less favourable treatment outcomes.  
 At the same time, our findings underscored the need to consider the complexity of the 
treatment context. When we tested the same baseline model but this time with treatment 
setting instead of therapists’ beliefs as additional factor, we found that the treatment setting 
explained the therapist effect equally well in our sample. Less favourable beliefs about 
treatment manuals and higher post-treatment fatigue levels were in fact largely consistent with 
the setting where treatment was delivered. In particular one MHC, in which a stepped care 
variant of CBT for CFS was implemented, had the least favourable attitudes towards 
treatment manuals and the lowest treatment effects of manualised CBT for CFS. 
 This finding may tell us that therapists with less positive attitudes towards treatment 
manuals tend to work in settings that tolerate or facilitate these attitudes. If this was the case, 
MHCs with therapists who largely hold unfavourable attitudes towards treatment manuals 
should receive additional attention in the dissemination of evidence-based practice for CFS to 
avoid suppression of established therapy effects. However, due to the small sample size of 
MHCs we cannot preclude that our findings may also be a consequence of the implementation 
scenario in which the attitude of the therapist does not play a vital role. Either way, our 
findings suggest that the context in which patients receive treatment seems to play a role in 
the accomplishment of therapy effects. The role of contextual factors that may impede central 
mechanisms of successful change may thereby be generally more important outside 
specialised treatment settings due to a greater heterogeneity of these settings. 
 
IMPLEMENTING EVIDENCE-BASED PRACTICE FOR CFS 
Numerous studies have highlighted the complexity of implementing evidence-based care into 
clinical practice (e.g. Kitson et al., 1998; Grol & Grimshaw, 1999; Greenhalgh et al., 2004; 
Cheater et al., 2005; Hemmelgarn et al., 2006, McHugh & Barlow, 2010). Successful 
implementation thereby depends on various factors which may be categorised into the nature 
of the evidence itself, the strategy which is used to facilitate the implementation process, and 
the context in which the intervention is implemented (Kitson et al., 1998).  
 
107 
Evidence 
There is by now extensive support from RCTs that CBT for CFS is an efficacious treatment 
for patients with CFS. The review by Bronwyn (2011) estimated that about 150 clinical trials 
with null results would be required to reduce the current effect size of CBT for CFS to a level 
that is no longer significant. Less is known about the effectiveness of CBT for CFS in clinical 
practice. The only two studies that reported about the effects of CBT for CFS outside the 
context of RCTs were conducted by Quarmby et al. (2007) and Scheeres et al. (2008a). 
Quarmby et al. (2007) compared treatment effects within and without the scope of a RCT 
in the same treatment unit. They found less favourable effect sizes outside the scope of their 
RCT and therefore concluded that CBT is less effective in clinical practice. It has been 
criticised, however, that only one experienced therapist treated all patients in the RCT 
condition which may have led to an inflation of the treatment effects in this condition 
(Scheeres et al., 2008a). Scheeres et al. (2008a) conducted a study in which CBT for CFS was 
implemented by a Dutch MHC and compared their findings with the results of four RCTs in 
which CBT for CFS was delivered. Their benchmark approach resulted in treatment effects of 
the MHC that were similar to those of RCTs. Consistently, they concluded that CBT for CFS 
does not have to be less effective in clinical practice and that MHCs seem to be suitable to 
deliver this treatment effectively. 
 
Strategy 
Scheeres et al. (2008a) paid particular attention to the conditions under which CBT for CFS 
can be implemented successfully outside specialised treatment units. Based on the 
recommendations of Grol et al. (1999), they conducted an analysis of potential barriers prior 
to the actual implementation process and designed interventions to overcome these barriers. 
The main problems that were anticipated were inexperience of therapists with the 
management of somatic complaints and a lack of awareness among referrers and patients 
about the new treatment. Their interventions included the training and supervision of 
therapists and regular activities to inform referrers and patients about CBT for CFS. Based on 
their experiences of the actual implementation process, they extended their list of conditions 
for successful implementation of CBT for CFS in MHCs. In particular, they added the aspect 
of starting treatments within a narrow time frame to avoid unexpectedly high drop-out rates. 
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These preconditions were discussed in an implementation manual which was designed to 
facilitate future implementations of CBT for CFS in MHCs independent of external support 
agents (Scheeres et al., 2006).  
In chapter 5, we explored whether MHCs are able to independently implement and 
sustain CBT for CFS based on the implementation manual. We monitored the implementation 
process of three Dutch MHCs for this purpose. One sustained CBT for CFS from the 
implementation study of Scheeres et al. (2008a). Two MHCs newly implemented CBT for 
CFS, one in the context of a stepped care program. We delivered the training and supervision 
for new therapists based on our treatment manual (Bleijenberg et al., 2003; Knoop et al., 
2010b) and introduced the implementation manual (Scheeres et al., 2006) to their team 
leaders. During the implementation process, substantial problems were detected based on our 
monitoring data so that external support in addition to the implementation manual was 
delivered to the two MHCs which newly implemented CBT for CFS. Ultimately, all MHCs 
reached the predefined implementation success criteria in terms of numbers of included 
patients and post-treatment assessments. A benchmark analysis revealed that overall treatment 
effect sizes were similar to those of RCTs, except for the MHC where a stepped care program 
for CFS was implemented.  
Our support for the two new MHCs was based on the work of Scheeres et al. (2006; 
2008a). The main part of our assistance included a translation of the standardised 
implementation manual of Scheeres et al. (2006) into practice based on regular feedback for 
team leaders about the performance of their MHC. In addition, we searched for further 
implementation problems and suggested solutions based on the specific needs of the MHCs 
(Grol et al., 1999, Cheater et al., 2005; Bosch et al., 2007). For example, treatment periods 
were often unexpectedly long which delayed the start of new treatments and increased the risk 
for drop-out. We therefore stimulated the administrative employees of the two MHCs to 
remind therapists of treatments which exceeded the recommended time frame of six months. 
We sought to empower team leaders during this process by communicating at eye level 
(Greenhalgh et al., 2004), leaving it to them to determine how much concrete support was 
delivered in addition to the regular feedback. According to the team leaders, both MHCs 
benefited from this assistance. 
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Although we expected that MHCs would be able to implement CBT for CFS without 
additional support, we experienced our assistance as substantially less intensive than that of 
the study by Scheeres et al. (2008a) where no implementation manual existed. Thus, even 
though the implementation manual does not seem to substitute additional support by external 
experts, it seems to help make the support more efficient. Our data further suggest that MHCs 
are able to sustain CBT for CFS independently after the initial implementation period. In 
general, there seem to be parallels between the need of therapists for supervision to deliver a 
new treatment approach based on a treatment manual and the need of team leaders for 
supervision to implement a new treatment approach based on an implementation manual 
(Fixsen et al., 2009). We obviously underestimated the latter need when we started with our 
implementation study. 
 
Context 
In chapter 6, we found that less favourable attitudes of therapists towards the use of treatment 
manuals predicted less effective treatments. In line with this finding, the utilisation of 
evidence-based practice by mental health care providers has generally been found to be 
associated with positive attitudes towards the evidence-based standard (Stahmer & Aarons, 
2009). However, in our sample, the setting where treatment was delivered was also a possible 
explanation for the variation in therapist efficacy. Less favourable attitudes and less effective 
treatments were actually augmented within the same treatment setting (i.e. the setting where 
stepped care for CFS was implemented). Besides the specific implementation scenario, other 
characteristics of the treatment setting, such as the organisational culture and climate towards 
evidence-based practice (Hemmelgarn et al., 2006; Aarons & Sawitzky, 2006), may affect 
successful dissemination of evidence-based practice for CFS. These characteristics may 
interact with characteristics of the therapists that deliver treatment at these settings. 
 
Stepped care 
Even though regular CBT for CFS was less effective in the MHC with the stepped care 
approach, the results of the minimal intervention were promising at this MHC. Recovery rates 
outranged those of a waiting list control group and were similar to those found in our 
specialised treatment unit (Knoop et al., 2008). Yet, due to the less favourable treatment effect 
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sizes in the regular CBT condition, implementation of the minimal intervention can better be 
postponed until cognitive behavioural therapists have had sufficient time to develop a certain 
routine in delivering regular CBT for CFS.  
As additional part of the stepped care approach, patients who do not recover from CFS 
after regular CBT may be referred to specialised tertiary care settings. In our implementation 
study, additional treatment in such a specialised setting was an option for all patients who did 
not respond to treatment in one of the MHCs. However, few patients were actually referred. 
Interestingly, a considerable number of non-responders were not even asked by their 
therapists whether or not they would appreciate specialised care, even though it was agreed 
upon by all professionals that every patient who did not recover according to our criteria 
would be offered a referral to tertiary care as a standard procedure. When patients were 
referred to a specialised setting in the context of our study, they often benefited from that 
intervention. However, the number of patients was small and there may be a selection bias as 
therapists may be more likely to refer patients of whom they think that additional treatment 
might work. 
 
POTENTIAL LIMITS OF EVIDENCE-BASED PRACTICE FOR CFS 
In chapter 7, we examined illness-specific characteristics of homebound patients and found 
that these patients differ considerably from patients who usually participate in treatment 
studies (Wiborg et al., 2010b). Homebound patients were characterised by extreme scores on 
daily fatigue and functional impairment, a predominant somatic attribution, and extremely 
passive activity patterns. Particularly striking to us was the fact that these extreme scores were 
stable across time while none accepted our offer to receive treatment. 
 Our data suggest that these patients may have accepted the fact that there is no suitable 
treatment for them. In particular, we found that the scores on psychological distress and loss 
of control were not inflated despite their extreme scores on physical complaints and 
functional impairment. Due to their predominant somatic attributions, these patients may also 
find any treatment unacceptable which is not strictly somatic in nature. The lack of motivation 
in these patients to follow a cognitive behavioural intervention might thereby be understood 
as a very powerful determinant of the treatment response at a pre-treatment level. 
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The clinical guidelines for the management of CFS of the National Institute for Health and 
Clinical Excellence in the UK suggest to motivate patients with such severe CFS by 
explaining the associated health risks of their current behaviour to them (Turnbull et al., 2007; 
pp. 36-37). This explanation should be accompanied with the offer of individually tailored 
activity management programs based on the principles of CBT and GET for CFS which can 
be delivered at home or by telephone and internet. Future studies will have to show how 
effective such motivational interventions are and whether previous findings about evidence-
based practice for CFS will generalise to this group of patients. 
 At the same time, preventive actions might be considered to help avoid the extreme 
illness patterns found in homebound patients. Most importantly, the rigidity of somatic 
attributions might be prevented by health care professionals who offer an explanatory model 
for the symptoms that encompasses an interplay of biological, psychological and social 
factors early in the development of CFS. Such a model has been shown to positively affect the 
responsiveness of patients with medically unexplained symptoms towards psychotherapeutic 
interventions and their prognosis to profit from these interventions (Dowrick et al., 2004).  
 A lack of knowledge and scepticism towards the diagnosis and treatment of CFS at the 
level of the health care professional may interfere with such a balanced approach in the 
disadvantage of the patient who is withheld from evidence-based practice (Wiborg et al., 
2008). Written informational interventions may help to inform professionals about the state of 
the art in the management of CFS and increase referrals to evidence-based interventions 
(Scheeres et al., 2007).   
 
FUTURE DIRECTIONS 
Research about mechanisms of change and determinants of the treatment response 
Although our mediation analyses generated valuable insights about how CBT for CFS may 
work, our findings clearly need to be validated by replication. The role of changes in 
perceptual and attentional biases could thereby be examined in all variants of evidence-based 
practice for CFS to determine whether these changes are general features of successful 
treatment for CFS. Prospective studies which are specifically designed to measure treatment 
process will help to determine causality among the factors of our model and help to shed light 
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to the role of temporary changes in physical activity in the treatment of CFS. Future studies 
should also examine the hypothesis of moderated mediation in pervasively passive patients. 
A maximum of three-quarter of the effect of treatment on fatigue and physical 
functioning was accounted for by the mediators of our treatment model. In case of overall 
impairment, only about half of the effect of treatment was explained by our mediators. The 
introduction of focusing on fatigue to our model, assessed as in the studies by Moss-Morris et 
al. (2005) or Wiborg et al. (2011), may substantially enhance the overall mediation effect. 
However, other factors may also contribute to our model. Promising candidates are self-
efficacy with respect to activity as well as acceptance of emotional distress and fatigue 
(Godfrey et al., 2007; Brooks et al., 2011). In case of overall impairment, balanced levels of 
social support may substantially contribute to the mediation effect as well (Prins et al., 2004). 
More research on the determinants of unfavourable treatment responses in community-based 
settings is needed to better understand which variables may threaten established therapy 
effects outside specialised treatment settings. Among other things, the exact role of the 
attitude of therapists towards treatment manuals (Addis et al., 2000) as well as specific 
characteristics of the treatment setting, such as the organisational climate and culture towards 
evidence-based practice (Hemmelgarn et al., 2006; Aarons & Sawitzky, 2006), should be 
further examined. Specific interventions could be developed and tested based on these new 
insights to positively influence unfavourable characteristics of the dissemination context 
whenever possible. 
 
National implementation of stepped care 
An estimated minimum of 30.000 to 40.000 people suffer from CFS in the Netherlands 
(Gezondheidsraad, 2005). Treatment settings for the delivery of evidence-based interventions 
for CFS are scarce so that many of these people do not receive adequate treatment. Based on 
the available findings, the implementation of stepped care for CFS on a national scale is 
feasible and cost-effective for MHCs after a period of initial investment (Tummers et al., 
2011; van Dam et al., 2011). Implementing CBT for CFS is also cost-effective from a societal 
perspective by helping to cut the immense health costs of these patients (McCrone et al., 
2004; Severens et al., 2004; Scheeres et al., 2008b). State grants which are designed to tackle 
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problems with the initial investment may help to stimulate MHCs to implement stepped care 
for CFS. 
The general pursuit of national implementation of stepped care for CFS is to facilitate 
early intervention based on the evidence-based standard in the region of the patient. 
Treatment effects should thereby be continuously monitored by MHCs to warrant high quality 
of care. According to our experience, CFS therapists should have followed the basic training 
for cognitive behaviour therapy of the Dutch association for behavioural and cognitive 
therapy (VGCT) as a minimum. After training in CBT for CFS, therapists should have the 
possibility to treat at least six, preferably more, CFS patients per year to develop a routine in 
the treatment of these patients. Our centre has initiated an accreditation of CFS therapists 
which may serve as a guide for adequate quality of care. In the context of a train the trainers 
program, therapists can also learn to train and supervise colleagues which can help to further 
cut costs for MHCs. 
Concerning the implementation process, we suggest that new implementations of 
evidence-based practice for CFS are accompanied by external experts during a period of two 
to three years depending on the implementation scenario and the needs of the individual 
MHC. This assistance can be based on the implementation manual of Scheeres et al. (2006) 
and includes regular feedback on the treatment process and outcome data. In the context of 
stepped care, we suggest that cognitive behavioural therapists get the opportunity to develop a 
routine in the delivery of regular CBT first. About one to two years of practice should be 
appropriate depending on the outcomes of the individual treatment setting. Special training 
for cognitive behavioural therapists in treating patients who did not recover after the minimal 
intervention may be offered in addition to avoid suppression of established therapy effects. 
In the context of stepped care for CFS, empirically supported selection criteria are needed 
to determine which patients should receive the low intensity intervention and which patients 
could better directly start with regular CBT for CFS. Some patients may also need to be 
referred directly to specialised tertiary care settings. There are already data which suggest that 
the minimal intervention is not suitable for patients with very severe disabilities (Knoop et al., 
2008). With evidence-based selection criteria, one single tailored treatment might suffice to 
facilitate substantial improvement which would make stepped care more efficient and 
effective by minimising the chance of non-response (Bower et al., 2005). Finally, the 
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readiness of MHC therapists to refer patients to tertiary care settings might be increased by 
demonstrating that these settings are effective in treating complex patients who did not yet 
recover. 
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According to the consensus criteria of the US Centre for Disease Control, chronic fatigue 
syndrome (CFS) is characterised by severe fatigue which lasts for at least six months. 
Additional complaints such as pain, concentration problems and unrefreshing sleep are 
frequently reported. These complaints are not the result of a medical condition and lead to 
substantial impairment. Cognitive behaviour therapy (CBT) is an evidence-based intervention 
for patients with CFS. Despite the available evidence for the efficacy of cognitive behavioural 
interventions for CFS, little is known about the mechanisms of change that are at work in 
these interventions. In this thesis, we tested some of the most influential models about how 
these interventions might generate their effects. In addition, we were interested in how CBT 
for CFS can be successfully implemented outside specialised treatment settings. In chapter 1, 
a detailed introduction to the topic was presented together with the outline of the thesis. 
 
Physical activity programs are a common way to treat patients with CFS. In these programs, 
the level of physical activities is gradually increased. Consistently, the idea that an increase in 
physical activity could be responsible for the improvement of CFS patients is widely held. In 
chapter 2, we tested whether the effect of CBT on fatigue severity is mediated by a persistent 
increase in physical activity. For this purpose, we reanalysed three randomised controlled 
trials (RCTs) that were previously conducted in the context of CBT for CFS. In all samples, 
actigraphy was used to assess the level of physical activity prior and subsequent to a treatment 
or control group period. Although CBT reduced fatigue, it did not change the level of physical 
activity. Changes in physical activity were also not related to changes in fatigue. Across the 
samples, we found a mean mediation effect of physical activity of about 1% of the total 
treatment effect which did not yield significance. We therefore concluded that the effect of 
CBT on fatigue in CFS is not mediated by a persistent increase in physical activity. 
 
In chapter 3, we examined whether CBT for CFS works because it affects maladaptive coping 
strategies. We were interested in whether the effect of CBT for CFS on fatigue and 
impairment is mediated by a decrease in avoidance behaviour and focusing on fatigue. The 
role of these strategies in the perpetuation of symptoms has been stressed by the cognitive 
behavioural model for CFS. We reanalysed the largest of our RCTs for this purpose in which 
a coping questionnaire was used to assess how patients react to their fatigue. Mediation 
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analysis revealed that a decrease in focusing on fatigue mediated the effect of CBT for CFS 
on fatigue and impairment. Neither avoidance of activity nor avoidance of aversive stimuli 
were significantly changed by treatment and were therefore excluded from mediation 
analysis. We concluded that a decrease in the focus on fatigue contributes to the treatment 
effect of CBT for CFS. 
 
Based on the findings of chapters 2 and 3, we developed and tested a treatment model for 
cognitive behavioural interventions focusing on CFS in chapter 4. We were interested in 
whether CBT for CFS might work because it leads to a persistent change in cognitive 
processes. These processes include (1) a decrease in focusing on symptoms, (2) a decrease in 
perceived problems with activity and (3) an increase in sense of control over fatigue. We 
hypothesised that these changes might mediate the effect of our intervention on fatigue 
severity and disabilities. We tested these hypotheses in the most recent of our RCTs in which 
a low intensity variant of CBT for CFS was compared to a waiting list control group. 
Structural equation modelling resulted in a model in which the effect of treatment was 
mediated by a decrease in perceived problems with activity and an increase in sense of control 
over fatigue. We concluded that cognitive behavioural interventions for CFS need to change 
the illness perception and beliefs of their patients in order to be effective. 
 
In chapter 5, we presented the monitoring data of three Dutch community-based mental 
health care centres (MHCs) which implemented or sustained CBT for CFS based on an 
implementation manual. In contrast to what we expected, the two MHCs that implemented 
CBT for CFS needed assistance in addition to the implementation manual. This support was 
delivered during the second half of the implementation process. All settings ultimately 
reached the predefined criteria for successful implementation with overall treatment effect 
sizes being similar to those found in RCTs. Only one MHC, which implemented CBT 
simultaneously with a low intensity intervention in the context of stepped care for CFS, 
produced significantly lower effect sizes in the regular CBT condition. These findings suggest 
that external support in addition to an implementation manual is needed to help coordinate the 
initial implementation of CBT for CFS. After initial implementation, MHCs seem able to 
sustain CBT for CFS successfully without additional support. The treatment effect sizes were 
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promising with respect to large-scale dissemination of CBT for CFS outside specialised 
treatment settings. Successive implementation of cognitive behavioural interventions for CFS 
should be considered in the context of stepped care for CFS. 
 
In chapter 6, we used the routinely collected outcome data of the three MHCs to explore the 
role of the therapist in the dissemination of manualised CBT for CFS outside specialised 
treatment settings. Ten therapists, who all received the same training in CBT for CFS, and 
103 patients with CFS were included. Random effects modelling revealed a significant 
difference in mean post-treatment fatigue between therapists. This effect could be explained 
by the therapists’ attitude towards working with evidence-based treatment manuals. However, 
we found that the treatment setting where patients received CBT for CFS could explain the 
findings equally well. We therefore concluded that the context in which patients receive CBT 
for CFS may play an important role in the accomplishment of established therapy effects 
outside specialised treatment settings. 
 
A substantial number of CFS patients seem to experience periods in which they are bound to 
home due to their symptomatology. Despite the ever growing body of knowledge about CFS, 
little is known about patients who feel no longer able to leave their house. In chapter 7, we 
compared the characteristics of these patients with those of other CFS patients who 
participated in the natural course condition of a RCT. Besides experiencing more impairment 
in daily functioning than the participants of the RCT, homebound patients were characterised 
by extremely high levels of daily fatigue, predominant somatic attributions and pervasively 
passive activity patterns. The course of symptomatology was stable in both groups. We 
concluded that homebound patients seem to form a distinct subgroup of CFS patients. 
 
In chapter 8, the findings of the previous chapters were discussed in more detail. At first, 
mechanisms of change and determinants of the treatment response of evidence-based 
interventions for CFS were discussed. Based on our findings, a persistent change in cognitive 
processes seems to be central to CBT for CFS. The context in which CFS patients receive 
treatment may thereby affect therapy outcomes. A focus on central change processes and 
modifications in the design and delivery of CBT for CFS in reaction to poor responses may 
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help to enhance the generally moderate efficacy of treatment. Next, we discussed the 
dissemination of CBT for CFS in MHCs, including strategies which may help to facilitate 
implementation success. We also commented on potential limits of evidence-based practice 
for CFS based on our findings about homebound patients. Finally, we discussed directions for 
future research and made suggestions for national implementation of stepped care for CFS. 
 
  
 
 
 
 
 
 
 
 
 
 
Samenvatting 
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Volgens de consensus criteria van het US Centre for Disease Control wordt het chronisch 
vermoeidheidssyndroom (CVS) gekenmerkt door ernstige vermoeidheid die tenminste zes 
maanden voortduurt. Er worden vaak ook additionele klachten, zoals pijn of concentratie- en 
slaapproblemen, gerapporteerd. Deze klachten zijn niet het gevolg van een somatische 
aandoening en zorgen voor aanzienlijke beperkingen in het dagelijks functioneren. Cognitieve 
gedragstherapie (CGT) is een bewezen werkzame behandeling voor patiënten met CVS. 
Hoewel er veel onderzoek naar de effectiviteit van CGT voor CVS is gedaan, is er nog weinig 
bekend over de mechanismen die het effect van de behandeling bewerkstelligen. In dit 
proefschrift werden sommige van de meest invloedrijke modellen getest over hoe deze 
behandelingen zouden kunnen werken. Daarnaast waren wij geïnteresseerd in de vraag hoe 
CGT voor CVS het beste in de praktijk geïmplementeerd zou kunnen worden. In hoofdstuk 1 
werden achtergrond en vraagstellingen van dit proefschrift geïntroduceerd. 
 
Lichamelijke activiteiten programma’s zijn een gebruikelijke manier om patiënten met CVS 
te behandelen. In deze programma’s wordt het niveau van lichamelijke activiteit stapsgewijs 
uitgebreid. Het idee is dat een toename van lichamelijke activiteit helpt om minder moe te 
worden. In hoofdstuk 2 werd de hypothese getoetst dat een toename van lichamelijke activiteit 
het effect van CGT voor CVS medieert. Daarvoor werden drie gerandomiseerde en 
gecontroleerde trials (RCTs), waarin de effectiviteit van CGT voor CVS werd getoetst, 
opnieuw geanalyseerd. In alle steekproeven werd Actigrafie gebruikt om lichamelijke 
activiteit voor en na de behandeling of controle conditie te meten. Alhoewel de behandeling 
leidde tot een afname van vermoeidheid, veranderde de behandeling het niveau van 
lichamelijke activiteit niet. Veranderingen in lichamelijke activiteit en vermoeidheid waren 
bovendien niet gerelateerd aan elkaar. Het effect van de behandeling dat door een toename 
van lichamelijke activiteit gemedieerd werd lag bij ongeveer 1 procent en was in geen van de 
studies significant. We concludeerden daarom dat het positieve effect van CGT op 
vermoeidheid bij CVS niet door een blijvende toename in fysieke activiteit gemedieerd wordt. 
 
In hoofdstuk 3 werd de hypothese getoetst dat de vermoeidheid in CGT voor CVS afneemt 
omdat dysfunctionele coping strategieën worden veranderd. Getoetst werd of het effect van 
CGT voor CVS op vermoeidheid en beperkingen gemedieerd werd door een afname in 
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vermijdingsgedrag en een afname in de gerichtheid op vermoeidheid. Beide coping 
strategieën hebben een prominente plaats in het cognitief-gedragsmatig model voor CVS. We 
analyseerden de grootste van onze drie trials waarin een coping vragenlijst werd afgenomen 
om patiënten te vragen hoe zij met vermoeidheid omgaan. De mediatieanalyse liet zien dat 
een afname in de gerichtheid op vermoeidheid het effect van CGT voor CVS op vermoeidheid 
en beperkingen medieerde. De vermijding van activiteit en aversieve stimuli werd 
daarentegen niet door de behandeling veranderd en werd daarom geëxcludeerd van een 
verdere mediatie analyse. We concludeerden dat een afname in de gerichtheid op 
vermoeidheid een bijdrage levert aan het effect van CGT voor CVS. 
 
Gebaseerd op de bevindingen in hoofdstuk 2 en 3, werd in hoofdstuk 4 een model voor de 
behandeling van patiënten met CGT voor CVS ontwikkeld en getoetst. De vraag was of CGT 
voor CVS werkt via een blijvende verandering in cognitieve processen. Deze processen 
betreffen (1) een afname in de gerichtheid op vermoeidheid (2) een afname in ervaren 
problemen met activiteit en (3) een toename in ervaren controle over de klachten. 
Verondersteld werd dat deze veranderingen het effect van onze interventie op vermoeidheid 
en beperkingen zou mediëren. Deze hypothesen werden in onze meest recente trial getoetst 
waarin een minimale variant van CGT voor CVS vergeleken werd met een wachtlijst controle 
conditie. Structural equation modelling leverde een model op waarin een afname in ervaren 
problemen met activiteit en een toename in ervaren controle over de vermoeidheid het effect 
van de behandeling medieerde. We concludeerden dat CGT voor CVS de waarneming van en 
gedachten over de aandoening moet veranderen om effectief te zijn. 
 
In hoofdstuk 5 presenteerden wij gegevens van drie Nederlandse GGZ instellingen waarvan 
twee CGT voor CVS op basis van een implementatie handleiding implementeerden en één 
GGZ instelling een eerdere implementatie voortzette. In tegenstelling tot wat wij hadden 
verwacht was er bij de twee nieuwe instellingen extra ondersteuning nodig naast de 
implementatie handleiding. Deze ondersteuning werd tijdens de tweede helft van het 
implementatieproces geleverd. Alle GGZ instellingen hebben uiteindelijk de van tevoren 
vastgestelde criteria voor succesvolle implementatie behaald. De effectiviteit van de 
uitgevoerde behandelingen was daarbij vergelijkbaar met die van RCTs. Slechts één GGZ 
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instelling, waar reguliere CGT gelijktijdig met een minimale interventie voor CVS werd 
geïmplementeerd in het kader van getrapte zorg, liet minder goede resultaten zien bij reguliere 
CGT. Deze bevindingen laten zien dat GGZ instellingen in de eerste periode van de 
implementatie van CGT voor CVS ondersteuning van externe deskundigen nodig hebben, wil 
de implementatie slagen. Daarna lijken deze instellingen in staat de geïmplementeerde 
behandeling op eigen kracht zonder verdere ondersteuning voort te kunnen zetten. De 
resultaten uit deze studie zijn veelbelovend met het oog op landelijke implementatie van CGT 
voor CVS. Op basis van de geringere resultaten van reguliere CGT in geval van 
implementatie van getrapte zorg, werd voorgesteld eerst reguliere CGT voor CVS te 
implementeren en pas later de minimale interventie. 
 
In hoofdstuk 6 hebben we de gegevens van de drie GGZ instellingen verder geanalyseerd om 
de rol van therapeuten bij de implementatie van CGT voor CVS buiten specialistische 
behandelcentra te onderzoeken. Tien therapeuten die allemaal dezelfde training in CGT voor 
CVS hadden gevolgd en 103 patiënten met CVS werden geïncludeerd. Random effects 
modelling liet zien dat er significante verschillen in effecten waren tussen de therapeuten. 
Deze verschillen konden door de houding van therapeuten ten opzichte van protocollair 
werken worden verklaard. De verschillen waren echter ook te verklaren door de instelling 
waar CGT voor CVS aangeboden werd. We concludeerden daarom dat de context waarin 
patiënten voor CVS behandeld worden, zou kunnen verklaren waarom behandeleffecten 
buiten specialistische centra verschillen. 
 
Een substantieel aantal CVS patiënten lijkt perioden te kennen waarin zij door hun klachten 
aan huis of bed gebonden zijn. Er zijn echter nauwelijks data beschikbaar over patiënten die 
zich niet in staat voelen huis of bed te verlaten. In hoofdstuk 7 hebben we de kenmerken van 
deze patiënten vergeleken met die van andere CVS patiënten die in de natuurlijk beloop 
conditie van een RCT zaten. De patiënten die aangaven niet in staat te zijn huis of bed te 
verlaten waren niet alleen meer beperkt in hun dagelijks functioneren. Deze patiënten hadden 
ook meer extreme dagelijkse vermoeidheid, sterkere somatische attributies en waren 
lichamelijk duidelijk minder actief dan de patiënten uit de RCT. Het verloop van de klachten 
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was stabiel in beide groepen. We concludeerden dat patiënten die aangeven huis of bed niet te 
kunnen verlaten een aparte subgroep van CVS patiënten vormen. 
 
In hoofdstuk 8 werden de resultaten uit de eerdere hoofdstukken besproken. Als eerste werden 
de veranderingsmechanismen en determinanten van de behandelrespons bij bewezen 
werkzame behandelingen voor CVS besproken. Op basis van onze bevindingen lijkt een 
blijvende verandering in cognitieve processen een centrale rol in de behandeling van CVS te 
spelen. Tevens lijkt de context waarin patiënten behandeling ontvangen de behandelresultaten 
te beïnvloeden. Meer aandacht voor de verandering van deze cognitieve processen en de 
manier waarop CGT voor CVS wordt aangeboden zou de effecten van de behandeling verder 
kunnen verbeteren. Vervolgens werd de verspreiding van CGT voor CVS in de GGZ 
besproken en werden suggesties gedaan welke implementatiestrategieën hierbij kunnen 
helpen. We bespraken bovendien mogelijke grenzen van bewezen werkzame behandelingen 
voor CVS op basis van onze bevindingen over patiënten die aan bed of huis zijn gebonden. 
Tot slot werden aanbevelingen voor toekomstig onderzoek en landelijke implementatie van 
stepped care voor CVS gedaan. 
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